10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

FORM 10-Q

(Mark One)

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2022

o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from __________ to __________

Commission File Number 1-12604

THE MARCUS CORPORATION

(Exact name of registrant as specified in its charter)

Wisconsin	39-1139844
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)
100 East Wisconsin Avenue, Suite 1900 Milwaukee ,Wisconsin	53202-4125
(Address of principal executive offices)	(Zip Code)

Registrant’s telephone number, including area code: (414) 905-1000

Securities registered pursuant to Section 12(b) of the Act:

Title of each class	Trading symbol(s)	Name of each exchange on which registered
Common Stock, $1.00 par value	MCS	New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to filing requirements for the past 90 days.

Yes x No o

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).

Yes x No o

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act (Check One).

Large accelerated filer	o	Accelerated filer	x
Non-accelerated filer	o	Smaller reporting company	o
		Emerging growth company	o

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).

Yes o No x

Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.

COMMON STOCK OUTSTANDING AT AUGUST 1, 2022 – 24,395,412

CLASS B COMMON STOCK OUTSTANDING AT AUGUST 1, 2022 –7,110,875

THE MARCUS CORPORATION

INDEX

		Page
PART I – FINANCIAL INFORMATION
Item 1.	Consolidated Financial Statements:
	Consolidated Balance Sheets	3
	Consolidated Statements of Earnings (Loss)	5
	Consolidated Statements of Comprehensive Income (Loss)	6
	Consolidated Statements of Cash Flows	7
	Condensed Notes to Consolidated Financial Statements	8
Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations	16
Item 3.	Quantitative and Qualitative Disclosures About Market Risk	29
Item 4.	Controls and Procedures	29
PART II – OTHER INFORMATION
Item 1A.	Risk Factors	30
Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds	30
Item 4.	Mine Safety Disclosures	30
Item 6.	Exhibits	30
	Signatures	S-1

2

PART I – FINANCIAL INFORMATION

Item 1. Consolidated Financial Statements

THE MARCUS CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)

	June 30, 2022		December 30, 2021
ASSETS
Current assets:
Cash and cash equivalents	$	57,741	$	17,658
Restricted cash	5,677		6,396
Accounts receivable, net of reserves of $169 and $1,001, respectively	26,273		28,902
Government grants receivable	—		4,335
Refundable income taxes	—		22,435
Assets held for sale	521		4,856
Other current assets	19,683		15,364
Total current assets	109,895		99,946
Property and equipment:
Land and improvements	129,802		129,642
Buildings and improvements	766,057		756,974
Leasehold improvements	167,316		166,060
Furniture, fixtures and equipment	383,997		375,650
Finance lease right-of-use assets	75,262		75,124
Construction in progress	3,652		6,000
Total property and equipment	1,526,086		1,509,450
Less accumulated depreciation and amortization	770,460		738,258
Net property and equipment	755,626		771,192
Operating lease right-of-use assets	209,264		217,072
Other assets:
Investments in joint ventures	2,202		2,335
Goodwill	75,052		75,095
Deferred incomes taxes	10,198		10,032
Other	12,398		12,689
Total other assets	99,850		100,151
TOTAL ASSETS	$	1,174,635	$	1,188,361

See accompanying condensed notes to consolidated financial statements.

3

THE MARCUS CORPORATION

Consolidated Balance Sheets

(in thousands, except share and per share data)

	June 30, 2022		December 30, 2021
LIABILITIES AND SHAREHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	38,335	$	35,781
Income taxes	283		—
Taxes other than income taxes	19,219		19,566
Accrued compensation	18,879		20,474
Other accrued liabilities	59,334		59,678
Short-term borrowings	46,628		47,346
Current portion of finance lease obligations	2,489		2,561
Current portion of operating lease obligations	16,291		16,795
Current maturities of long-term debt	11,077		10,967
Total current liabilities	212,535		213,168
Finance lease obligations	16,116		17,192
Operating lease obligations	207,713		216,064
Long-term debt	203,720		204,177
Deferred income taxes	25,125		26,183
Other long-term obligations	56,693		57,963
Equity:
Shareholders’ equity attributable to The Marcus Corporation
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued	—		—
Common Stock, $1 par; authorized 50,000,000 shares; issued 24,498,243 shares at June 30, 2022 and 24,345,356 shares at December 30, 2021	24,498		24,345
Class B Common Stock, $1 par; authorized 33,000,000 shares; issued and outstanding 7,110,875 shares at June 30, 2022 and 7,130,125 shares at December 30, 2021	7,111		7,130
Capital in excess of par	150,565		145,656
Retained earnings	283,364		289,306
Accumulated other comprehensive loss	(10,529)		(11,444)
	455,009		454,993
Less cost of Common Stock in treasury (112,282 shares at June 30, 2022 and 48,111 shares at December 30, 2021)	(2,276)		(1,379)
Total shareholders’ equity attributable to The Marcus Corporation	452,733		453,614
Noncontrolling interest	—		—
Total equity	452,733		453,614
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	$	1,174,635	$	1,188,361

See accompanying condensed notes to consolidated financial statements.

4

THE MARCUS CORPORATION

Consolidated Statements of Earnings (Loss)

(in thousands, except per share data)

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Revenues:
Theatre admissions	$	63,087	$	24,915	$	101,504	$	35,600
Rooms	28,865		17,332		46,295		26,376
Theatre concessions	58,147		23,061		93,611		32,980
Food and beverage	19,014		9,591		33,525		15,503
Other revenues	21,192		14,231		39,999		26,125
	190,305		89,130		314,934		136,584
Cost reimbursements	8,250		3,417		15,863		6,750
Total revenues	198,555		92,547		330,797		143,334
Costs and expenses:
Theatre operations	61,737		28,877		106,165		47,147
Rooms	10,471		7,072		18,674		12,337
Theatre concessions	22,993		10,037		38,186		14,533
Food and beverage	15,035		7,806		27,175		13,176
Advertising and marketing	5,978		3,819		10,459		6,368
Administrative	17,627		15,963		36,708		29,279
Depreciation and amortization	16,752		18,494		33,983		36,473
Rent	6,578		6,344		12,828		12,685
Property taxes	4,980		4,468		9,725		9,207
Other operating expenses	9,261		8,628		18,935		13,418
Impairment charges	—		3,732		—		3,732
Reimbursed costs	8,250		3,417		15,863		6,750
Total costs and expenses	179,662		118,657		328,701		205,105
Operating income (loss)	18,893		(26,110)		2,096		(61,771)
Other income (expense):
Investment income (loss)	(459)		120		(727)		160
Interest expense	(4,063)		(4,907)		(8,155)		(9,750)
Other expense	(584)		(628)		(1,161)		(1,256)
Gain (loss) on disposition of property, equipment and other assets	(69)		(164)		355		2,040
Equity earnings ( losses) from unconsolidated joint ventures	7		—		(134)		—
	(5,168)		(5,579)		(9,822)		(8,806)
Earnings (loss) before income taxes	13,725		(31,689)		(7,726)		(70,577)
Income tax expense ( benefit)	4,765		(8,323)		(1,784)		(19,081)
Net earnings (loss)	8,960		(23,366)		(5,942)		(51,496)
Net earnings (loss) attributable to noncontrolling interests	—		—		—		—
Net earnings (loss) attributable to The Marcus Corporation	$	8,960	(23,366)		$	(5,942)	$	(51,496)
Net earnings (loss) per share - basic:
Common Stock	$	0.29	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.26	$	(0.68)	$	(0.18)	$	(1.44)
Net earnings (loss) per share - diluted:
Common Stock	$	0.24	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.23	$	(0.68)	$	(0.18)	$	(1.44)

See accompanying condensed notes to consolidated financial statements.

5

THE MARCUS CORPORATION

Consolidated Statements of Comprehensive Income (Loss)

(in thousands)

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Net earnings (loss)	$	8,960	$	(23,366)	$	(5,942)	$	(51,496)
Other comprehensive income (loss), net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect of $67, $86, $134 and $172 , respectively	190		242		380		484
Fair market value adjustment of interest rate swap, net of tax effect (benefit) of $37, $(2), $116 and $4, respectively	106		(7)		329		10
Reclassification adjustment on interest rate swap included in interest expense, net of tax effect of $31, $43, $72 and $111, respectively	88		121		206		314
Other comprehensive income	384		356		915		808
Comprehensive income (loss)	9,344		(23,010)		(5,027)		(50,688)
Comprehensive earnings (loss) attributable to noncontrolling interests	—		—		—		—
Comprehensive income (loss) attributable to The Marcus Corporation	$	9,344	$	(23,010)	$	(5,027)	$	(50,688)

See accompanying condensed notes to consolidated financial statements.

6

THE MARCUS CORPORATION

Consolidated Statements of Cash Flows

(in thousands)

	26 Weeks Ended
	June 30, 2022		July 1, 2021
OPERATING ACTIVITIES:
Net loss	$	(5,942)	$	(51,496)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Losses on investments in joint ventures	134		—
Gain on disposition of property, equipment and other assets	(355)		(2,040)
Impairment charges	—		3,732
Depreciation and amortization	33,983		36,473
Amortization of debt issuance costs	826		1,244
Share-based compensation	4,572		4,152
Deferred income taxes	(1,505)		(19,181)
Other long-term obligations	(49)		1,180
Contribution of the Company’s stock to savings and profit-sharing plan	956		1,012
Changes in operating assets and liabilities:
Accounts receivable	2,629		(4,944)
Government grants receivable	4,335		4,913
Other assets	(4,294)		(1,712)
Operating leases	(1,047)		(2,484)
Accounts payable	551		6,369
Income taxes	22,720		6,003
Taxes other than income taxes	(347)		(654)
Accrued compensation	(1,595)		6,650
Other accrued liabilities	(344)		1,102
Total adjustments	61,170		41,815
Net cash provided by (used in) operating activities	55,228		(9,681)
INVESTING ACTIVITIES:
Capital expenditures	(16,341)		(6,195)
Proceeds from disposals of property, equipment and other assets	4,821		4,297
Purchase of trading securities	—		(1,906)
Other investing activities	45		59
Net cash used in investing activities	(11,475)		(3,745)
FINANCING ACTIVITIES:
Debt transactions:
Proceeds from borrowings on revolving credit facility	22,000		66,500
Repayment of borrowings on revolving credit facility	(22,000)		(46,500)
Repayments on short-term borrowings	(820)		(4,150)
Principal payments on long-term debt	(851)		(187)
Debt issuance costs	—		(4)
Principal payments on finance lease obligations	(1,336)		(1,329)
Equity transactions:
Treasury stock transactions, except for stock options	(1,461)		(1,236)
Exercise of stock options	79		1,374
Net cash (used in) provided by financing activities	(4,389)		14,468
Net increase in cash, cash equivalents and restricted cash	39,364		1,042
Cash, cash equivalents and restricted cash at beginning of period	24,054		14,088
Cash, cash equivalents and restricted cash at end of period	$	63,418	$	15,130
Supplemental Information:
Interest paid, net of amounts capitalized	$	7,054	$	7,719
Income taxes refunded, including interest earned	22,998		5,910
Change in accounts payable for additions to property, equipment and other assets	2,003		400

See accompanying condensed notes to consolidated financial statements.

7

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

1. General

Basis of Presentation - The unaudited consolidated financial statements for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 30, 2022, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 30, 2021.

Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 30, 2021, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.

Noncontrolling Interests - The Company has an ownership interest greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is included in the accounts of the Company. The Company is the primary beneficiary of the VIE and the Company’s interest is considered a majority voting interest. The equity interest of outside owners in consolidated entities is recorded as noncontrolling interests in the consolidated balance sheets, and their share of earnings is recorded as net earnings (loss) attributable to noncontrolling interests in the consolidated statements of earnings (loss) in accordance with the partnership agreement. Due to the cumulative losses of the entity, the noncontrolling interest balance is $0 as of June 30, 2022 and December 30, 2021. The Company will not record earnings or losses from noncontrolling interest until the entity returns to profitability.

Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $16,744 and $33,967 for the 13 and 26 weeks ended June 30, 2022, respectively, and $18,475 and $36,433 for the 13 and 26 weeks ended July 1, 2021, respectively.

Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of June 30, 2022, assets held for sale consists primarily of excess land.

Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022.

Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022 or July 1, 2021.

Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the

diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.

Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Numerator:
Net earnings (loss) attributable to The Marcus Corporation	$	8,960	$	(23,366)	$	(5,942)	$	(51,496)
Denominator:
Denominator for basic EPS	31,492		31,404		31,469		31,300
Effect of dilutive employee stock options	40		—		—		—
Effect of convertible notes	9,085		—		—		—
Denominator for diluted EPS	40,617		31,404		31,469		31,300
Net earnings (loss) per share - basic:
Common Stock	$	0.29	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.26	$	(0.68)	$	(0.18)	$	(1.44)
Net earnings (loss) per share - diluted:
Common Stock	$	0.24	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.23	$	(0.68)	$	(0.18)	$	(1.44)

For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect. During the 26 weeks ended June 30, 2022, and the 13 and 26 weeks ended July 1, 2021, approximately 61,791, 165,439 and 142,746 common stock equivalents, respectively, were excluded from the computation of diluted loss per share due to the Company’s net loss. During the 26 weeks ended June 30, 2022, and the 13 and 26 weeks ended July 1, 2021, 9,084,924 shares related to the convertible notes were excluded from the computation of diluted loss per share as the effect would have been anti-dilutive.

Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021 was as follows:

	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 30, 2021	$	24,345	$	7,130	$	145,656	$	289,306	$	(11,444)	$	(1,379)	$	453,614	$	—	$	453,614
Exercise of stock options	—		—		(5)		—		—		31		26		—		26
Purchase of treasury stock	—		—		—		—		—		(1,373)		(1,373)		—		(1,373)
Savings and profit-sharing contribution	56		—		900		—		—		—		956		—		956
Reissuance of treasury stock	—		—		1		—		—		8		9		—		9
Issuance of non-vested stock	78		—		(236)		—		—		158		—		—		—
Shared-based compensation	—		—		2,917		—		—		—		2,917		—		2,917
Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	19		(19)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(14,902)		531		—		(14,371)		—		(14,371)
BALANCES AT MARCH 31, 2022	$	24,498	$	7,111	$	149,234	$	274,403	$	(10,913)	$	(2,555)	$	441,778	$	—	$	441,778
Exercise of stock options	—		—		(16)		—		—		69		53		—		53
Purchase of treasury stock	—		—		—		—		—		(104)		(104)		—		(104)
Reissuance of treasury stock	—		—		(2)		—		—		9		7		—		7
Issuance of non-vested stock	—		—		(305)		—		—		305		—		—		—
Shared-based compensation	—		—		1,655		—		—		—		1,655		—		1,655
Other	—		—		(1)		1		—		—		—		—		—
Comprehensive income	—		—		—		8,960		384		—		9,344		—		9,344
BALANCES AT JUNE 30, 2022	$	24,498	$	7,111	$	150,565	$	283,364	$	(10,529)	$	(2,276)	$	452,733	$	—	$	452,733

	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 31, 2020	$	23,264	$	7,926	$	153,529	$	331,897	$	(14,933)	$	(2,960)	$	498,723	$	—	$	498,723
Adoption of ASU No. 2020-06	—		—		(16,511)		702		—		—		(15,809)		—		(15,809)
Exercise of stock options	—		—		(659)		—		—		1,951		1,292		—		1,292
Purchase of treasury stock	—		—		—		—		—		(1,181)		(1,181)		—		(1,181)
Savings and profit-sharing contribution	44		—		968		—		—		—		1,012		—		1,012
Reissuance of treasury stock	—		—		2		—		—		10		12		—		12
Issuance of non-vested stock	221		—		(367)		—		—		146		—		—		—
Shared-based compensation	—		—		1,484		—		—		—		1,484		—		1,484
Other	—		—		—		(1)		—		1		—		—		—
Conversions of Class B Common Stock	520		(520)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(28,130)		452		—		(27,678)		—		(27,678)
BALANCES AT APRIL 1, 2021	$	24,049	$	7,406	$	138,446	$	304,468	$	(14,481)	$	(2,033)	$	457,855	$	—	$	457,855
Exercise of stock options	—		—		(40)		—		—		122		82		—		82
Purchase of treasury stock	—		—		—		—		—		(73)		(73)		—		(73)
Reissuance of treasury stock	—		—		(1)		—		—		7		6		—		6
Issuance of non-vested stock	18		—		(157)		—		—		139		—		—		—
Shared-based compensation	—		—		2,668		—		—		—		2,668		—		2,668
Conversions of Class B Common Stock	275		(275)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(23,366)		356		—		(23,010)		—		(23,010)
BALANCES AT JULY 1, 2021	$	24,342	$	7,131	$	140,916	$	281,102	$	(14,125)	$	(1,838)	$	437,528	$	—	$	437,528

Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:

	June 30, 2022		December 30, 2021
Unrecognized gain (loss) on interest rate swap agreements	$	26	$	(509)
Net unrecognized actuarial loss for pension obligation	(10,555)		$	(10,935)
	$	(10,529)	$	(11,444)

Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.

The Company’s assets and liabilities measured at fair value are classified in one of the following categories:

Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 30, 2022 and December 30, 2021, respectively, the Company’s $3,789 and $4,617 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 30, 2022 and December 30, 2021, respectively, the Company’s $44,990 and $5,000 of investments in money market accounts were valued using Level 1 pricing inputs and were included in cash and cash equivalents.

Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At June 30, 2022 and December 30, 2021, respectively, the Company’s $34 asset and $689 liability related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs.

Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At June 30, 2022 and December 30, 2021, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets and liabilities that were measured on a non-recurring basis are discussed in Note 3.

Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Service cost	$	264	$	280	$	528	$	561
Interest cost	335		301		670		601
Net amortization of prior service cost and actuarial loss	257		327		514		655
Net periodic pension cost	$	856	$	908	$	1,712	$	1,817

Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.

Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 30, 2022 is as follows:

	13 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	63,087	$	—	$	—	$	63,087
Rooms	—		28,865		—		28,865
Theatre concessions	58,147		—		—		58,147
Food and beverage	—		19,014		—		19,014
Other revenues(1)	8,203		12,872		117		21,192
Cost reimbursements	—		8,250		—		8,250
Total revenues	$	129,437	$	69,001	$	117	$	198,555
	26 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	101,504	$	—	$	—	$	101,504
Rooms	—		46,295		—		46,295
Theatre concessions	93,611		—		—		93,611
Food and beverage	—		33,525		—		33,525
Other revenues(1)	13,813		25,975		211		39,999
Cost reimbursements	—		15,863		—		15,863
Total revenues	$	208,928	$	121,658	$	211	$	330,797

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the 13 and 26 weeks ended July 1, 2021 is as follows:

	13 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	24,915	$	—	$	—	$	24,915
Rooms	—		17,332		—		17,332
Theatre concessions	23,061		—		—		23,061
Food and beverage	—		9,591		—		9,591
Other revenues(1)	4,281		9,855		95		14,231
Cost reimbursements	44		3,373		—		3,417
Total revenues	$	52,301	$	40,151	$	95	$	92,547
	26 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	35,600	$	—	$	—	$	35,600
Rooms	—		26,376		—		26,376
Theatre concessions	32,980		—		—		32,980
Food and beverage	—		15,503		—		15,503
Other revenues(1)	6,196		19,734		195		26,125
Cost reimbursements	87		6,663		—		6,750
Total revenues	$	74,863	$	68,276	$	195	$	143,334

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The Company had deferred revenue from contracts with customers of $39,355 and $39,144 as of June 30, 2022 and December 30, 2021, respectively. The Company had no contract assets as of June 30, 2022 and December 30, 2021. During the 26 weeks ended June 30, 2022, the Company recognized revenue of $9,448 that was included in deferred revenues as of December 30, 2021. During the 26 weeks ended July 1, 2021, the Company recognized revenue of $4,115 that was included in deferred revenues as of December 31, 2020. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.

As of June 30, 2022, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $3,228 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. The Company recognizes revenue as the tickets are redeemed, which is expected to occur within the next two years.

As of June 30, 2022, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $3,559 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.

The majority of the Company’s revenue is recognized in less than one year from the original contract.

New Accounting Pronouncements – During the first quarter of fiscal 2022, the Company adopted Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendments in this update provide increased transparency of government assistance including the requirement of certain disclosures in a company’s notes to the consolidated financial statements about transactions with a government. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (LIBOR), or other interbank offered rates, to alternative reference rates such as the Secured Overnight Financing Rate (SOFR). ASU No. 2020-14 is optional, effective immediately, and may be elected over time as reference rate reform activities occur, generally through December 31, 2022. The Company will evaluate the effect the new standard will have on its consolidated financial statements when a replacement rate is chosen.

2. Impact of COVID-19 Pandemic

The COVID-19 pandemic has had an unprecedented impact on the world and both of the Company’s business segments. As an operator of movie theatres, hotels and resorts, restaurants and bars, each of which consists of spaces where customers and guests gather in close proximity, the Company’s businesses were significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic, and the customers’ reactions or responses to such actions. The extent of these protective actions and their impact on the Company’s businesses has continued to dissipate during the first half of fiscal 2022.

The Company began fiscal 2022 with all of its theatres open with normal operating days and hours. While still below pre-COVID-19 levels, attendance has continued to gradually improve as the number of vaccinated individuals increased, more films are released, and customers indicate increasing willingness to return to movie theatres.

The Company began fiscal 2022 with all eight of its company-owned and managed hotels open. The majority of the Company’s restaurants and bars in its hotels and resorts were open during the first quarters of fiscal 2022, operating under applicable state and local restrictions and guidelines, and in some cases reduced operating hours. The majority of the Company’s hotels and restaurants are generating reduced revenues as compared to pre-COVID-19 pandemic years, although hotel occupancy continues to improve as the travel activity increases.

Since the COVID-19 pandemic began, the Company has been working proactively to preserve cash and enhance liquidity. As of June 30, 2022, the Company had cash and cash equivalents of approximately $57,741 and $221,809 of availability under its $225,000 revolving credit facility. With this strong liquidity position, combined with cash generated from operations and proceeds from the sale of surplus real estate, the Company believes it is positioned to meet its obligations as they come due and continue to sustain its operations throughout fiscal 2022 and 2023, even if the properties continue to generate reduced revenues during these periods.

8

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

During the first quarter of fiscal 2022, the Company received a $22,959 federal income tax refund (including $636 of interest) related to its fiscal 2020 tax return, with the primary benefit derived from net operating loss carrybacks to prior years. The Company also received $4,335 in state theatre grants during the first quarter of fiscal 2022 that were awarded during the fourth quarter of fiscal 2021.

The Company believes that the actions that have been taken will allow it to have sufficient liquidity to meet its obligations as they come due and to comply with its debt covenants for at least 12 months from the issuance date of these unaudited consolidated financial statements. However, future compliance with the Company’s debt covenants are dependent upon the timing of new movie releases and the protective actions that federal, state and local governments have taken which impact consumer confidence and the speed of recovery of the Company’s theatres and hotels and resorts businesses. The Company’s estimates and assumptions related to future forecasted results of the Company are subject to inherent risk and uncertainty due to the ongoing impact of the COVID-19 pandemic, and actual results could differ materially from estimated amounts and impact the Company’s ability to comply with its debt covenants.

3. Impairment Charges

During the 13 weeks ended July 1, 2021, the Company determined that indicators of impairment were evident at certain theatre asset groups. For certain of the theatre asset groups evaluated for impairment, the sum of the estimated undiscounted future cash flows attributable to these assets was less than their carrying amount. The Company evaluated the fair value of these assets, consisting primarily of leasehold improvements, furniture, fixtures and equipment, and operating lease right-of-use-assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset, including estimated sales proceeds) was less than their carrying values and recorded a $3,732 impairment loss, reducing certain property and equipment and certain operating lease right-of-use assets. The remaining net book value of the impaired assets was $10,200 as of July 1, 2021, excluding any applicable remaining lease obligations. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022.

4. Long-Term Debt and Short-Term Borrowings

Long-term debt and short-term borrowings are summarized as follows:

	June 30, 2022		December 30, 2021
Mortgage notes	$	24,203	$	24,388
Senior notes	90,000		90,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	1,158		1,356
Convertible senior notes	100,050		100,050
Payroll Protection Program loans	2,712		3,181
Revolving credit agreement	—		—
Debt issuance costs	(3,326)		(3,831)
Total debt, net of debt issuance costs	214,797		215,144
Less current maturities, net of issuance costs	11,077		10,967
Long-term debt	$	203,720	204,177
Short-term borrowings	46,628		47,346
Total debt and short-term borrowings, net of issuance costs	$	261,425	$	262,490

9

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

Credit Agreement and Short-Term Borrowings

On January 9, 2020, the Company replaced its then-existing credit agreement with several banks. On April 29, 2020, the Company entered into the First Amendment, on September 15, 2020, the Company entered into the Second Amendment, and on July 13, 2021, the Company entered into the Third Amendment (the Credit Agreement, as amended by the First Amendment, the Second Amendment and the Third Amendment, hereinafter referred to as the “Credit Agreement”).

The Credit Agreement provides for a revolving credit facility that matures on January 9, 2025 with an initial maximum aggregate amount of availability of $225,000. At June 30, 2022, there were borrowings of $0 outstanding on the revolving credit facility, which when borrowed, bear interest at LIBOR plus a margin, effectively 6.10% at June 30, 2022. Availability under the line at June 30, 2022, was $221,809, after taking into consideration outstanding letters of credit that reduce revolver availability. In conjunction with the First Amendment, the Company added an initial $90,800 term loan facility that was scheduled to mature on September 22, 2021. In conjunction with the Third Amendment, the term loan facility was reduced to $50,000 and the maturity date was extended to September 22, 2022. As of June 30, 2022, the balance of the term loan was $46,628, which is included in short-term borrowings on the consolidated balance sheet.

Borrowings under the Credit Agreement generally bear interest at a variable rate equal to: (i) LIBOR, subject to a 1% floor, plus a specified margin based upon the Company’s consolidated debt to capitalization ratio as of the most recent determination date; or (ii) the base rate (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month LIBOR), subject to a 1% floor, plus a specified margin based upon the Company’s consolidated debt to capitalization ratio as of the most recent determination date. In addition, the Credit Agreement generally requires the Company to pay a facility fee equal to 0.125% to 0.25% of the total revolving commitment, depending on its consolidated debt to capitalization ratio, as defined in the Credit Agreement. However, pursuant to the First Amendment and the Second Amendment: (A) in respect of revolving loans, (1) the Company is charged a facility fee equal to 0.40% of the total revolving credit facility commitment and (2) the specified margin is 2.35% for LIBOR borrowings and 1.35% for ABR borrowings, which facility fee rate and specified margins will remain in effect until the end of the first fiscal quarter ending after the end of any period in which any portion of the term loan facility remains outstanding or the testing of any financial covenant in the Credit Agreement is suspended (the “specified period”); and (B) in respect of term loans, the specified margin is 2.75% for LIBOR borrowings and 1.75% for ABR borrowings, in each case, at all times.

The Credit Agreement contains various restrictions and covenants. Among other requirements, the Credit Agreement (a) limits the amount of priority debt (as defined in the Credit Agreement) held by the Company’s restricted subsidiaries to no more than 20% of the Company’s consolidated total capitalization (as defined in the Credit Agreement), (b) limits the Company’s permissible consolidated debt to capitalization ratio to a maximum of 0.55 to 1.0, (c) requires the Company to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 as of the end of the fiscal quarter ending March 30, 2023 and each fiscal quarter thereafter, (d) restricts the Company’s ability to incur additional indebtedness, pay dividends and other distributions (the restriction on dividends and other distributions does not apply to subsidiaries), and make voluntary prepayments on or defeasance of the Company’s 4.02% Senior Notes due August 2025, 4.32% Senior Notes due February 2027, the notes or certain other convertible securities, (e) requires the Company’s consolidated EBITDA not to be less than or equal to (i) $10,000 as of December 30, 2021 for the two consecutive fiscal quarters then ending, (ii) $25,000 as of March 31, 2022 for the three consecutive fiscal quarters then ending, (iii) $50,000 as of June 30, 2022 for the four consecutive fiscal quarters then ending, (iv) $65,000 as of September 29, 2022 for the four consecutive fiscal quarters then ending, or (v) $70,000 as of December 29, 2022 for the four consecutive fiscal quarters then ending, (f) requires the Company’s consolidated liquidity not to be less than or equal to (i) $100,000 as of September 30, 2021, (ii) $100,000 as of December 30, 2021, (iii) $100,000 as of March 31, 2022, (iv) $100,000 as of June 30, 2022, or (v) $50,000 as of the end of any fiscal quarter thereafter until and including the fiscal quarter ending December 29, 2022; however, each such required minimum amount of consolidated liquidity would be reduced to $50,000 for each such testing date if the initial term loans are paid in full as of such date, and (g) prohibits the Company from incurring or making capital expenditures, (i) during fiscal 2021 in excess of the sum of $40,000 plus certain adjustments, or (ii) during the Company’s 2022 fiscal year in excess of $50,000 plus certain adjustments. See Note 9 for further discussion of an amendment to the Credit Agreement covenants subsequent to the end of the second quarter of fiscal 2022.

10

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

Pursuant to the Credit Agreement, the Company is required to apply net cash proceeds received from certain events, including certain asset disposition, casualty losses, condemnations, equity issuances, capital contributions, and the incurrence of certain debt, to prepay outstanding term loans. During the 26 weeks ended June 30, 2022, approximately $820 in asset sale proceeds were applied to the term loan balance. In addition, if, at any time during the specified period, the Company’s unrestricted cash on hand exceeds $75,000, the Company is required to prepay revolving loans under the Credit Agreement by the amount of such excess, without a corresponding reduction in the revolving commitments under the Credit Agreement.

In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement. The foregoing security interests, liens and guaranties will remain in effect until the Collateral Release Date (as defined in the Credit Agreement).

The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.

Note Purchase Agreements

At June 30, 2022 and December 30, 2021, the Company’s $90,000 of senior notes consist of two Purchase Agreements maturing in 2025 through 2027, require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 4.32%.

Convertible Senior Notes

On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee.

The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradeable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

Upon conversion, the Convertible Notes may be settled, at the Company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate is 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. If the Company undergoes certain fundamental changes,

11

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

holders of Convertible Notes may require the Company to repurchase for cash all or part of their Convertible Notes for a purchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a make-whole fundamental change occurs prior to the maturity date, the Company will, under certain circumstances, increase the conversion rate for holders who convert Convertible Notes in connection with such make-whole fundamental change. The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes. The Indenture includes covenants customary for securities similar to the Convertible Notes, sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company and certain of its subsidiaries after which the Convertible Notes become automatically due and payable.

During the Company’s fiscal 2021 second, third and fourth quarters, and the Company’s fiscal 2022 first, second and third quarters, the Company’s Convertible Notes were (are) eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. As such, the Convertible Notes will continue to be classified as long-term. Future convertibility and resulting balance sheet classification of this liability will be monitored at each quarterly reporting date and will be analyzed dependent upon market prices of the Company’s Common Stock during the prescribed measurement period. No Convertible Notes have been converted to date and the Company does not expect any to be converted within the next 12 months.

Derivatives

The Company utilizes derivatives principally to manage market risks and reduce its exposure resulting from fluctuations in interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategies for undertaking various hedge transactions.

The Company entered into two interest rate swap agreements on March 1, 2018 covering $50,000 of floating rate debt. The first agreement had a notional amount of $25,000, expired March 1, 2021 and required the Company to pay interest at a defined rate of 2.559% while receiving interest at a defined variable rate of one-month LIBOR. The second agreement has a notional amount of $25,000, expires March 1, 2023 and requires the Company to pay interest at a defined rate of 2.687% while receiving interest at a defined variable rate of one-month LIBOR (1.063% at June 30, 2022). The Company’s interest rate swap agreement is considered effective and qualifies as a cash flow hedge. The Company assesses, both at the inception of each hedge and on an on-going basis, whether the derivatives that are used in its hedging transactions are highly effective in offsetting changes in cash flows of the hedged items. As of June 30, 2022, the remaining interest rate swap was considered highly effective. The fair value of the interest rate swap on June 30, 2022 was an asset of $34, which is included in other current assets in the consolidated balance sheet. The fair value of the interest rate swap on December 30, 2021, was a liability of $689, which was included in other long-term obligations in the consolidated balance sheet. The Company does not expect the interest rate swap to have a material effect on earnings over its remaining term.

5. Leases

The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to accounting guidance ASU No. 2016-02, Leases (Topic 842). The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.

The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

12

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

Total lease cost consists of the following:

		13 Weeks Ended				26 Weeks Ended
Lease Cost	Classification	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Finance lease costs:
Amortization of finance lease assets	Depreciation and amortization	$	696	$	668	$	1,401	$	1,380
Interest on lease liabilities	Interest expense	216		240		437		490
		$	912	$	908	$	1,838	$	1,870
Operating lease costs:
Operating lease costs	Rent expense	$	6,364	$	6,465	$	12,741	$	12,786
Variable lease cost	Rent expense	178		(158)		15		(173)
Short-term lease cost	Rent expense	36		37		72		72
		$	6,578	$	6,344	$	12,828	$	12,685

Additional information related to leases is as follows:

	13 Weeks Ended				26 Weeks Ended
Other Information	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases	$	752	$	699	$	1,336	$	1,329
Operating cash flows from finance leases	216		240		437		490
Operating cash flows from operating leases	7,012		7,899		14,136		$	15,292
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities	116		—		188		—
Operating lease liabilities	—		—		183		1,575

	June 30, 2022		December 30, 2021
Finance leases:
Property and equipment – gross	$	75,262	$	75,124
Accumulated depreciation and amortization	(59,552)		(58,197)
Property and equipment - net	$	15,710	$	16,927

13

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

Remaining lease terms and discount rates are as follows:

Lease Term and Discount Rate	June 30, 2022		December 30, 2021
Weighted-average remaining lease terms:
Finance leases	8 years		8 years
Operating leases	13 years		13 years
Weighted-average discount rates:
Finance leases	4.58	%	4.58	%
Operating leases	4.60	%	4.48	%

Deferred rent payments of approximately $1,442 for the Company’s operating leases have been included in the total operating lease obligations as of June 30, 2022, of which approximately $698 is included in long-term operating lease obligations.

6. Income Taxes

The Company’s effective income tax rate for the 13 and 26 weeks ended June 30, 2022 was 34.7% and 23.1%, respectively, and was 26.3% and 27.0% for the 13 and 26 weeks ended and July 1, 2021, respectively. The effective tax rate for the 13 weeks ended June 30, 2022 includes discrete tax expense related to various matters. During the 26 weeks ended July 1, 2021, the Company filed income tax refund claims of $24,151 related to its fiscal 2020 tax return, of which $1,828 was received in fiscal 2021, and $22,323 was received during the 26 weeks ended June 30, 2022. An additional $636 of interest was received during the 26 weeks ended June 30, 2022 and is included within income tax benefit in the consolidated statement of earnings (loss). During the 26 weeks ended July 1, 2021, the Company received the remaining $5,900 of requested tax refunds from its fiscal 2019 tax return.

7. Joint Venture Transactions

During the 26 weeks ended July 1, 2021, the Company sold its interest in an equity investment without a readily determinable fair value for $4,150 and recorded a gain of $2,079, which is included in gain (loss) on disposition of property, equipment and other assets in the consolidated statement of earnings (loss).

8. Business Segment Information

The Company’s primary operations are reported in the following business segments: Theatres and Hotels/Resorts. Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.

14

THE MARCUS CORPORATION

CONDENSED NOTES TO CONSOLIDATED FINANCIAL STATEMENTS

FOR THE 13 AND 26 WEEKS ENDED JUNE 30, 2022

(in thousands, except share and per share data)

Following is a summary of business segment information for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021:

13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	129,437	$	69,001	$	117	$	198,555
Operating income (loss)	16,430		6,817		(4,354)		18,893
Depreciation and amortization	11,863		4,801		88		16,752
13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
July 1, 2021
Revenues	$	52,301	$	40,151	$	95	$	92,547
Operating loss	$	(18,215)	$	(2,239)	$	(5,656)	$	(26,110)
Depreciation and amortization	$	13,385	$	5,047	$	62	$	18,494
26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	208,928	$	121,658	$	211	$	330,797
Operating income (loss)	8,410		3,843		(10,157)		2,096
Depreciation and amortization	24,054		9,751		178		33,983
26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
July 1, 2021
Revenues	$	74,863	$	68,276	$	195	$	143,334
Operating loss	(43,854)		(7,947)		(9,970)		(61,771)
Depreciation and amortization	26,171		10,174		128		36,473

9. Subsequent Events

Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022 the Company repaid $46,628 of short-term borrowings, repaying in full and retiring the term loan facility maturing on September 22, 2022. In connection with the repayment of the term loan, the Company amended the Credit Agreement by entering into the Fourth Amendment which modified the consolidated fixed charge coverage covenant, reducing the requirement to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 to at least 2.5 to 1 starting as of the end of the fiscal quarter ending March 30, 2023, and continuing for each fiscal quarter thereafter.

Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022, the Board of Directors declared a regular quarterly cash dividend of $0.05 per share of common stock. The dividend will be paid September 15, 2022, to shareholders of record on August 25, 2022. The Board of Directors also declared a dividend of $0.045 per share on the Class B common stock. The dividend on the Class B commons stock, which is not publicly traded, will also be paid September 15, 2022, to shareholders of record on August 25, 2022.

15

THE MARCUS CORPORATION

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations

Special Note Regarding Forward-Looking Statements

Certain matters discussed in this Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) and elsewhere in this Form 10-Q are “forward-looking statements” intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. These forward-looking statements may generally be identified as such because the context of such statements include words such as we “believe,” “anticipate,” “expect” or words of similar import. Similarly, statements that describe our future plans, objectives or goals are also forward-looking statements. Such forward-looking statements are subject to certain risks and uncertainties which may cause results to differ materially from those expected, including, but not limited to, the following: (1) the adverse effects of the COVID-19 pandemic on our theatre and hotels and resorts businesses, results of operations, liquidity, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness; (2) the duration of the COVID-19 pandemic and related government restrictions and the level of customer demand following the relaxation of such requirements; (3) the availability, in terms of both quantity and audience appeal, of motion pictures for our theatre division (particularly following the COVID-19 pandemic, during which the release dates for certain motion pictures have been postponed), as well as other industry dynamics such as the maintenance of a suitable window between the date such motion pictures are released in theatres and the date they are released to other distribution channels; (4) the effects of adverse economic conditions in our markets, including but not limited to, those caused by the COVID-19 pandemic; (5) the effects of adverse economic conditions, including but not limited to, those caused by the COVID-19 pandemic, on our ability to obtain financing on reasonable and acceptable terms, if at all; (6) the effects on our occupancy and room rates caused by the COVID-19 pandemic and the effects on our occupancy and room rates caused by the relative industry supply of available rooms at comparable lodging facilities in our markets; (7) the effects of competitive conditions in our markets; (8) our ability to achieve expected benefits and performance from our strategic initiatives and acquisitions; (9) the effects of increasing depreciation expenses, reduced operating profits during major property renovations, impairment losses, and preopening and start-up costs due to the capital intensive nature of our business; (10) the effects of changes in the availability of and cost of labor and other supplies essential to the operation of our business; (11) the effects of weather conditions, particularly during the winter in the Midwest and in our other markets; (12) our ability to identify properties to acquire, develop and/or manage and the continuing availability of funds for such development; (13) the adverse impact on business and consumer spending on travel, leisure and entertainment resulting from terrorist attacks in the United States, other incidents of violence in public venues such as hotels and movie theatres or epidemics (such as the COVID-19 pandemic); and (14) a disruption in our business and reputational and economic risks associated with civil securities claims brought by shareholders. These statements are not guarantees of future performance and are subject to risks, uncertainties and other factors, including developments related to the COVID-19 pandemic, some of which are beyond our control and difficult to predict and could cause actual results to differ materially from those expressed or forecasted in the forward-looking statements. Our forward-looking statements are based upon our assumptions, which are based upon currently available information, including assumptions about our ability to manage difficulties associated with or related to the COVID-19 pandemic; the assumption that our theatre closures, hotel closures and restaurant closures are not expected to be permanent or to re-occur; the continued availability of our workforce; and the temporary and long-term effects of the COVID-19 pandemic on our business. Shareholders, potential investors and other readers are urged to consider these factors carefully in evaluating the forward-looking statements and are cautioned not to place undue reliance on such forward-looking statements. The forward-looking statements made herein are made only as of the date of this Form 10-Q and we undertake no obligation to publicly update such forward-looking statements to reflect subsequent events or circumstances.

RESULTS OF OPERATIONS

General

We report our consolidated and individual segment results of operations on a 52- or 53-week fiscal year ending on the last Thursday in December. Fiscal 2022 is a 52-week year beginning on December 31, 2021 and ending on December 29, 2022. Fiscal 2021 was a 52-week year that began on January 1, 2021 and ended on December 30, 2021.

We divide our fiscal year into three 13-week quarters and a final quarter consisting of 13 or 14 weeks. The second quarter of fiscal 2022 consisted of the 13-week period beginning on April 1, 2022 and ended on June 30, 2022. The second quarter of fiscal 2021 consisted of the 13-week period beginning April 2, 2021 and ended on July 1, 2021. The first half of fiscal

16

2022 consisted of the 26-week period beginning on December 31, 2021 and ended on June 30, 2022. The first half of fiscal 2021 consisted of the 26-week period beginning January 1, 2021 and ended on July 1, 2021. Our primary operations are reported in the following two business segments: movie theatres and hotels and resorts. Within this MD&A, amounts for totals, subtotals, and variances may not recalculate exactly within tables due to rounding as they are calculated using the unrounded numbers.

For discussion regarding the impact of COVID-19 and related economic conditions on our results for the year ended December 30, 2021, see “Part II-Item 7-Management’s Discussion and Analysis of Financial Condition and Results of Operations” in our 2021 Annual Report. For further discussion regarding the impacts of COVID-19 and related economic conditions on our results for the first half of fiscal 2022 and potential future impacts, see immediately below, and also refer to the discussion of our operational risks and financial risks found in “Part I-Item 1A-Risk Factors” in our 2021 Annual Report.

Impact of the COVID-19 Pandemic

The COVID-19 pandemic has had an unprecedented impact on the world and both of our business segments. As an operator of movie theatres, hotels and resorts, restaurants and bars, each of which consists of spaces where customers and guests gather in close proximity, our businesses were significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic, and our customers’ reactions or responses to such actions. The extent of these protective actions and their impact on our businesses has continued to dissipate during the first half of fiscal 2022.

We began fiscal 2022 with all of our theatres open with normal operating days and hours. While still below pre-COVID-19 levels, attendance has continued to gradually improve as the number of vaccinated individuals increased, more films are released, and customers indicate increasing willingness to return to movie theatres. We remain optimistic that the theatre industry is in the process of rebounding and will continue to benefit from pent-up social demand now that a greater percentage of the population is vaccinated, the majority of state and local restrictions have been lifted and people seek togetherness with a return to normalcy.

We still expect a return to “normalcy” to span multiple months driven by an increase in the quality and quantity of new films released in theatres and a gradual ramp-up of consumer comfort with public gatherings. The appearance of first, the Delta variant, and subsequently the Omicron variant, of the disease has resulted in changing government guidance on indoor activities in some communities, which impacted consumer comfort early in fiscal 2022. Industry customer surveys indicate that consumer comfort is once again increasing, reaching a post-pandemic high comfort level in June 2022. We believe the approval of vaccines for children ages 5-11 has contributed to parents feeling more comfortable to visit a movie theatre, which should bolster the market for films aimed at children and families, a genre in which we have historically performed very well.

Total theatre division revenues, expressed as a percentage of fiscal 2019 revenues, increased every quarter of fiscal 2021, increasing from 20% in the first quarter to 32% in the second quarter, 59% in the third quarter and 82% in the fourth quarter. We were very encouraged by the performance of multiple films released during the first half of fiscal 2022, including Top Gun: Maverick, Doctor Strange in the Multiverse of Madness, The Batman, and Jurassic World: Dominion. Total theatre division revenues in the first and second quarters of fiscal 2022 expressed as a percentage of fiscal 2019 revenues were 69% and 80%, respectively.

We began fiscal 2022 with all eight of our company-owned and managed hotels open. Substantially all of our restaurants and bars in our hotels and resorts were open during the second quarter of fiscal 2022, operating in some cases with reduced operating hours. The majority of our hotels and restaurants are now generating revenues at or above pre-pandemic levels, while at certain hotels that primarily serve group business revenues remain below pre-pandemic levels with improving occupancy and business travel activity increasing. The primary customer for hotels during the second quarter of fiscal 2022 continued to come from the leisure travel market. While business travel remained below pre-pandemic levels during the second quarter of fiscal 2022, we continued to see an increase in travel from this customer segment, particularly from small and mid-size group activity. As of the date of this report, our group room revenue bookings for fiscal 2022—commonly referred to in the hotels and resorts industry as “group pace”—is running behind where we would typically be at this same time in prior years (pre-pandemic), but group pace has improved from earlier in the fiscal year and we have experienced increased booking activity in recent months for fiscal 2022 and 2023 and beyond. With companies implementing return to office plans, we remain optimistic that business travel will continue to increase during fiscal 2022 and beyond. Total hotel division revenues, expressed as a percentage of fiscal 2019 revenues, increased throughout fiscal 2021, including an

17

increase during fiscal 2021 from 51% in the first quarter to 57% in second quarter, 88% in the third quarter and 82% in the fourth quarter. Total hotel division revenues, expressed as a percentage of fiscal 2019 revenues, continued to increase during fiscal 2022 from 96% in the first quarter to 99% in the second quarter. The future economic environment will also have a significant impact on the pace of our return to “normal” hotel operations.

Maintaining and protecting a strong balance sheet has always been a core philosophy of The Marcus Corporation during our 87-year history, and, despite the COVID-19 pandemic, our financial position remains strong. As of June 30, 2022, we had a cash balance of approximately $57.7 million, $221.8 million of availability under our $225 million revolving credit facility and our debt-to-capitalization ratio (including short-term borrowings) was 0.37. Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022 we repaid $46.6 million of short-term borrowings, repaying in full and terminating the term loan facility maturing on September 22, 2022 and reducing our overall indebtedness. With our strong liquidity position, combined with cash generated from operations and proceeds from the sale of surplus real estate (discussed below), we believe we are positioned to meet our obligations as they come due and continue to sustain our operations throughout fiscal 2022 and 2023, even if our properties continue to generate reduced revenues during these periods.

During the first half of fiscal 2022 we received a $23.0 million federal income tax refund (including $0.7 million of interest) related to our fiscal 2020 tax return, with the primary benefit derived from net operating loss carrybacks to prior years. We also received $4.3 million in state theatre grants during the first half of fiscal 2022 that were awarded and accrued during the fourth quarter of fiscal 2021. Both the receipt of the income tax refund and grant funds contributed to our current strong liquidity position.

We continue to pursue sales of surplus real estate and other non-core real estate to further enhance our liquidity. During the first half of fiscal 2022, we sold three land parcels, generating net proceeds of approximately $4.8 million. We believe we may receive additional sales proceeds from real estate sales during the remainder of fiscal 2022 totaling approximately $1 - $5 million, depending upon demand for the real estate in question.

We cannot assure that the impact of the COVID-19 pandemic will not continue to have a material adverse effect on both our theatre and hotels and resorts businesses, results of operations, cash flows, financial condition, access to credit markets and ability to service our existing and future indebtedness.

Overall Results

The following table sets forth revenues, operating income (loss), other income (expense), net earnings (loss) and net earnings (loss) per diluted common share for the second quarter and first half of fiscal 2022 and fiscal 2021 (in millions, except for per share and variance percentage data):

	Second Quarter								First Half
					Variance								Variance
	F2022		F2021		Amt.		Pct.		F2022		F2021		Amt.		Pct.
Revenues	$	198.6	$	92.5	$	106.0	114.5	%	$	330.8	$	143.3	$	187.5	130.8	%
Operating income (loss)	18.9		(26.1)		45.0		172.4	%	2.1		(61.8)		63.9		103.4	%
Other income (expense)	(5.2)		(5.6)		0.4		7.4	%	(9.8)		(8.8)		(1.0)		(11.4)	%
Net earnings (loss) attributable to The Marcus Corp.	$	9.0	$	(23.4)	$	32.3	138.3	%	$	(5.9)	$	(51.5)	$	45.6	88.5	%
Net earnings (loss) per common share - diluted:	$	0.24	$	(0.76)	$	1.00	131.6	%	$	(0.19)	$	(1.71)	$	1.52	88.9	%

Revenues increased and operating income (loss), net earnings (loss) attributable to The Marcus Corporation and net earnings (loss) per diluted common share improved significantly during the second quarter and first half of fiscal 2022 compared to the fiscal 2021 periods. Increased revenues and operating income from both our theatre division and hotels and resorts division contributed to the improvement during the first half of fiscal 2022 compared to the first half of fiscal 2021, during portions of which some of our theatres were closed, releases of new films were limited and travel was significantly reduced due to the impact of the COVID-19 pandemic.

Our operating loss during the second quarter and first half of fiscal 2021 was negatively impacted by impairment charges of $3.7 million, or approximately $0.09 per diluted common share, primarily related to surplus real estate that was held for

18

sale. Our operating loss during the first half of fiscal 2021 was favorably impacted by state government grants of approximately $1.3 million, or approximately $0.03 per diluted common share.

Net earnings (loss) attributable to The Marcus Corporation during the second quarter and first half of fiscal 2022 was favorably impacted by decreased interest expense compared to the fiscal 2021 periods, partially offset by investment losses during the fiscal 2022 periods compared to investment gains in the fiscal 2021 periods, and lower gains on disposition of property, equipment and other assets during the first half of fiscal 2022 as compared to the first half of fiscal 2021.

We recognized investment losses of $0.5 million and $0.7 million during the second quarter and first half of fiscal 2022, respectively, compared to investment income of $0.1 million and $0.2 million for the respective fiscal 2021 periods. Variations in investment income were due to changes in the value of marketable securities.

Our interest expense totaled $4.1 million and $8.2 million for the second quarter and first half of fiscal 2022, respectively, compared to $4.9 million and $9.8 million for the respective fiscal 2021 periods. The decrease in interest expense for both periods in fiscal 2022 was primarily due to decreased borrowings and a decrease in non-cash amortization of deferred financing costs. Changes in our borrowing levels due to variations in our operating results, capital expenditures, acquisition opportunities (or the lack thereof) and asset sale proceeds, among other items, may impact, either favorably or unfavorably, our actual reported interest expense in future periods, as may changes in short-term interest rates.

We reported net gains on disposition of property, equipment and other assets of $0.4 million during the first half of fiscal 2022, compared to net gains on disposition of property, equipment and other assets of $2.0 million during the first half of fiscal 2021. The net gain on disposition of property, equipment and other assets during the first half of fiscal 2022 was due primarily to the sale of surplus land. The net gain on disposition of property, equipment and other assets during the first half of fiscal 2021 included the sale of an equity investment in a joint venture. The timing of periodic sales and disposals of our property, equipment and other assets varies from quarter to quarter, resulting in variations in our reported gains or losses on disposition of property, equipment and other assets. We anticipate additional disposition gains or losses from periodic sales of property, equipment and other assets during fiscal 2022 and beyond.

We reported income tax expense for the second quarter of fiscal 2022 of $4.8 million compared to an income tax benefit of $8.3 million during the second quarter of fiscal 2021. We reported an income tax benefit for the first half of fiscal 2022 of $1.8 million compared to an income tax benefit of $19.1 million during the first half of fiscal 2021. The income tax benefit during the fiscal 2021 periods was primarily the result of the significant losses before income taxes incurred as a result of the reduction in our operating performance due to the impact of the COVID-19 pandemic as described above. Our fiscal 2022 first half effective income tax rate was 23.1%. Our fiscal 2021 first half effective income tax rate was 27.0%. We anticipate that our effective income tax rate for the remaining quarters of fiscal 2022 may be in the 24-28% range, excluding any potential changes in federal or state income tax rates or other one-time tax benefits. Our actual fiscal 2022 effective income tax rate may be different from our estimated quarterly rates depending upon actual facts and circumstances.

Theatres

The following table sets forth revenues, operating income (loss) and operating margin for our theatre division for the second quarter and first half of fiscal 2022 and fiscal 2021 (in millions, except for variance percentage and operating margin):

	Second Quarter										First Half
							Variance										Variance
	F2022			F2021			Amt.		Pct.		F2022			F2021			Amt.		Pct.
Revenues	$	129.4		$	52.3		$	77.1	147.5	%	$	208.9		$	74.9		$	134.1	179.1	%
Operating income (loss)	16.4			(18.2)			34.6		190.1	%	8.4			(43.9)			52.3		119.1	%
Operating margin (% of revenues)	12.7		%	(34.8)		%					4.0		%	(58.6)		%

Our theatre division revenues and operating income increased significantly during the second quarter and first half of fiscal 2022 with all of our theatres open and an increase in new films released by movie studios, compared to the fiscal 2021 periods during portions of which a significant number of our theatres were temporarily closed and releases of new films were limited. We began the first quarter of fiscal 2021 with approximately 52% of our theatres open. As state and local

19

restrictions were eased in several of our markets and several new films were released by movie studios, we gradually reopened theatres, ending the fiscal 2021 first and second quarters with approximately 74% and 95% of our theatres open, respectively. The majority of our reopened theatres operated with reduced operating days (Fridays, Saturdays, Sundays and Tuesdays) and reduced operating hours during the fiscal 2021 first quarter, and by the end of May 2021 we had returned the vast majority of our theatres to normal operating days (seven days per week) and operating hours. Our theatres were open with normal operating days and hours at all of our theatres throughout the first half of fiscal 2022.

Although significantly improved compared to the prior year, our operating income during the second quarter and first half of fiscal 2022 was negatively impacted by increased film costs (discussed below) and increased labor and supply costs as a result of the current labor shortage and inflationary environment. Our operating income during the second quarter and first half of fiscal 2022 was favorably impacted by inflationary price increases taken later in the second quarter of fiscal 2022 in response to the increased labor and supply costs. Our operating loss during the second quarter and first half of fiscal 2021 was negatively impacted by impairment charges of $3.7 million primarily related to surplus real estate that was held for sale. Our fiscal 2021 first half operating loss would have been even larger if not for a nonrecurring state government grant of approximately $1.3 million that favorably impacted our theatre division operating loss.

The following table provides a further breakdown of the components of revenues for the theatre division for the second quarter and first half of fiscal 2022 and fiscal 2021 (in millions, except for variance percentage):

	Second Quarter								First Half
					Variance								Variance
	F2022		F2021		Amt.		Pct.		F2022		F2021		Amt.		Pct.
Admission revenues	$	63.1	$	24.9	$	38.2	153.2	%	$	101.5	$	35.6	$	65.9	185.1	%
Concession revenues	58.1		23.1		35.1		152.1	%	93.6		33.0		60.6		183.6	%
Other revenues	8.2		4.3		3.9		91.6	%	13.8		6.2		7.6		122.6	%
	129.4		52.3		77.2		147.7	%	208.9		74.8		134.2		179.4	%
Cost reimbursements	—		—		—		(100.0)	%	—		0.1		(0.1)		(100.0)	%
Total revenues	$	129.4	$	52.3	$	77.1	147.5	%	$	208.9	$	74.9	$	134.1	179.1	%

As described above, revenues were significantly reduced during the second quarter and first half of fiscal 2021 due to a limited number of films and the temporary closures and reduced operating days and hours at our theatres in response to the COVID-19 pandemic. As a result, we believe it is also beneficial to compare our revenues to pre-pandemic levels. The following table compares the components of revenues for the theatre division for the second quarter and first half of fiscal 2022 to the second quarter and first half of fiscal 2019 (in millions, except for variance percentage):

	Second Quarter								First Half
					Variance								Variance
	F2022		F2019		Amt.		Pct.		F2022		F2019		Amt.		Pct.
Admission revenues(1)	$	63.1	$	83.1	$	(20.0)	(24.0)	%	$	101.5	$	142.0	$	(40.5)	(28.5)	%
Concession revenues	58.1		67.9		(9.8)		(14.4)	%	93.6		115.1		(21.5)		(18.7)	%
Other revenues	8.2		11.2		(3.0)		(26.6)	%	13.8		19.7		(5.9)		(29.9)	%
	129.4		162.2		(32.7)		(20.2)	%	208.9		276.8		(67.9)		(24.5)	%
Cost reimbursements	—		0.2		(0.2)		(100.0)	%	—		0.4		(0.4)		(100.0)	%
Total revenues	$	129.4	$	162.4	$	(33.0)	(20.3)	%	$	208.9	$	277.3	$	(68.3)	(24.6)	%

(1)We acquired Movie Tavern theatres on February 1, 2019. Admission revenues for the first half of fiscal 2022 decreased 30.7% on a pro forma basis for the acquisition as of the first day of fiscal 2019.

According to data received from Comscore (a national box office reporting service for the theatre industry) and compiled by us to evaluate our fiscal 2022 second quarter and first half results, U.S. box office receipts decreased 26.6% during our fiscal 2022 second quarter and 34.2% during our fiscal 2022 first half compared to the same comparable weeks in fiscal 2019, indicating that our decrease in admission revenues during the second quarter of fiscal 2022 of 24.0% outperformed the industry by 2.6 percentage points. Our pro forma decrease in admission revenues during the first half of fiscal 2022 of 30.7% outperformed the industry by 3.5 percentage points. Based upon this metric, we believe we were once again one of

20

the top performing theatre circuits during fiscal 2022 compared to the top 10 circuits in the U.S. Additional data received and compiled by us from Comscore indicates our admission revenues during the second quarter and first half of fiscal 2022 represented approximately 3.3% of the total admission revenues in the U.S. during the periods (commonly referred to as market share in our industry). This represents a notable increase over our reported market share of approximately 3.1% during the comparable fiscal 2019 periods, prior to the pandemic. Our goal is to continue our past pattern of outperforming the industry, but with the majority of our renovations now completed, our ability to do so in any given quarter will likely be partially dependent upon film mix, weather and the competitive landscape in our markets.

Total theatre attendance increased significantly during the second quarter and first half of fiscal 2022 compared to the second quarter and first half of fiscal 2021, when a significant portion of our theatres were temporarily closed and the number of new films was more limited. Total theatre attendance increased 145.4% and 174.2% during the second quarter and first half of fiscal 2022, respectively, compared to the second quarter and first half of fiscal 2021, resulting in increases in both admission revenues and concession revenues. Conversely, a decrease in the number of new films and lingering customer concerns regarding visiting indoor businesses negatively impacted attendance during the second quarter and first half of fiscal 2022 as compared to the same periods in fiscal 2019.

Our highest grossing films during the fiscal 2022 second quarter included Top Gun: Maverick, Doctor Strange in the Multiverse of Madness, Jurassic World: Dominion, Sonic the Hedgehog 2 and The Bad Guys. All of these five films debuted with an exclusive theatrical run prior to release on streaming services. This compares with three of the top five films in the second quarter of fiscal 2021 that were released “day-and-date” on streaming services. We believe such “day-and-date” releases negatively impact theatrical revenues, particularly in week two and beyond of a films’ release. We also believe “day-and-date” releases increase piracy, further impacting potential revenues. We believe our theatre circuit outperformed its competition on two of our top five revenue producing films during the second quarter of fiscal 2022. In addition, we believe our overall admission revenue outperformed the industry due in part to the fact that we believe our theatre circuit outperformed its competition on the next tier of films. Due to the impact of three particularly strong blockbusters released during the second quarter of fiscal 2022 (Top Gun: Maverick, Doctor Strange in the Multiverse of Madness and Jurassic World: Dominion), the film slate during the second quarter of fiscal 2022 was weighted more towards our top movies compared to the second quarter of fiscal 2021 and fiscal 2019, as evidenced by the fact that our top five films during our fiscal 2022 second quarter accounted for 68% of our total box office results, compared to 56% and 52% for the top five films during the second quarter of fiscal 2021 and fiscal 2019 (prior to the pandemic), respectively, both expressed as a percentage of the total admission revenues for the period. An increased reliance on just a few blockbuster films during a given quarter often has the effect of increasing our film rental costs during the period, as generally the better a particular film performs, the greater the film rental cost tends to be as a percentage of box office receipts. As a result of a more concentrated film slate our overall film rental cost increased significantly during the second quarter of fiscal 2022 compared to the same period in the prior year.

Our average ticket price increased 3.3% during the second quarter of fiscal 2022 compared to the second quarter of fiscal 2021 and increased by 9.3% compared to the second quarter of fiscal 2019. Our average ticket price increased 4.0% during the first half of fiscal 2022 compared to the first half of fiscal 2021 and increased by 12.9% compared to the first half of fiscal 2019. In addition to inflationary price increases taken during the second quarter of fiscal 2022 in response to increases in labor and supply costs, a larger proportion of admission revenues from our proprietary premium large format screens (with a higher ticket price) contributed to the increase in our average ticket price during the first half of fiscal 2022. During portions of the first half of fiscal 2021 we also offered older “library” film product for only $5.00 per ticket when there was limited availability of new films resulting in a lower average ticket price in the same period in the prior year.

Our average concession revenues per person increased by 2.9% during the second quarter of fiscal 2022 compared to the second quarter of fiscal 2021 and increased by 23.0% compared to the second quarter of fiscal 2019. Our average concession revenues per person increased by 3.7% during the first half of fiscal 2022 compared to the first half of fiscal 2021 and increased by 28.5% compared to the first half of fiscal 2019. In addition, as customers have returned to “normal” activities such as going to the movie theatre, they have demonstrated a propensity to spend at a higher rate than before the pandemic closures. We also believe a portion of the increase in our average concession revenues per person during the first half of fiscal 2022 may be attributed to shorter lines at our concession stand due to reduced attendance (during periods of high attendance, some customers do not purchase concessions because the line is too long). A small portion of the increase in our average concession revenues per person is attributable to inflationary increases in concessions prices in response to increases in food and labor costs. Finally, we believe that an increased percentage of customers buying their concessions in advance using our website, kiosk or our mobile app likely contributed to higher average concession revenues per person, as our experience has shown that customers are more likely to purchase more items when they order and pay electronically.

21

We expect to continue to report increased average concession revenues per person in future periods, but whether our customers will continue to spend at these current significantly higher levels in future periods is currently unknown.

Other revenues increased by approximately $3.9 million during the second quarter of fiscal 2022 compared to the second quarter of fiscal 2021. Other revenues increased by approximately $7.6 million during the first half of fiscal 2022 compared to the first half of fiscal 2021. The increases were primarily due to the impact of increased attendance on internet surcharge ticketing fees and preshow and in-app advertising income.

Several films have performed well in the early weeks of our fiscal 2022 third quarter, including Thor: Love and Thunder, Minions 2 and Nope. Several films that were previously scheduled for release in the second half of fiscal 2022 have shifted release dates into fiscal 2023 due to production delays resulting from supply chain and COVID-19 related disruptions. We expect the lack of a significant number of blockbuster films, particularly during August, September and October, to negatively impact our operating results in the near-term, before the pace of new film releases is expected to increase once again. The current film product release schedule for the remainder of fiscal 2022 includes several new films that have potential to perform well, including DC League of Super-Pets, Bullet Train, Halloween Ends, Black Adam, Black Panther: Wakanda Forever, Avatar: The Way of Water, Puss in Boots: The Last Wish, and Shazam! Fury of the Gods. We believe that with a greater percentage of the population now vaccinated and consumer comfort now at post-pandemic highs, and assuming that concerns over any new variants of COVID-19 do not result in significant new restrictions, demand for out-of-home entertainment will continue to remain strong during the remainder of fiscal 2022. The early list of films scheduled to be released during fiscal 2023 appears quite strong.

Revenues for the theatre business and the motion picture industry in general are heavily dependent on the general audience appeal of available films, together with studio marketing, advertising and support campaigns and the maintenance of appropriate “windows” between the date a film is released in theatres and the date a motion picture is released to other channels, including premium video-on-demand (“PVOD”), video on-demand (“VOD”), streaming services and DVD. These are factors over which we have no control. We currently believe that “day-and-date” film release experiments such as those tested by Warner Brothers and Disney during 2021 will not become the normal plan of distribution as the pandemic fully subsides. Warner Brothers has indicated that it is returning to an exclusive 45-day theatrical window with a significant number of its films during fiscal 2022. Disney announced in early 2022 that they will retain flexibility for future film distribution, particularly for family films, but has released several films exclusively to theatrical in fiscal 2022 including Doctor Strange in the Multiverse of Madness, Lightyear, and Thor: Love and Thunder and has committed to exclusive theatrical releases for several upcoming films including Black Panther: Wakanda Forever.

We ended the second quarter of fiscal 2022 with a total of 1,064 company-owned screens in 85 theatres, compared to 1,091 company-owned screens in 88 theatres and six managed screens in one theatre at the end of the second quarter of fiscal 2021. As of the end of the second quarter of fiscal 2022 and the date of this report, all of our company-owned theatres are operating. As of the end of the second quarter of fiscal 2021 approximately 95% of our theatres were open and operating.

Hotels and Resorts

The following table sets forth revenues, operating income (loss) and operating margin for our hotels and resorts division for the second quarter and first half of fiscal 2022 and fiscal 2021 (in millions, except for variance percentage and operating margin):

	Second Quarter										First Half
							Variance										Variance
	F2022			F2021			Amt.		Pct.		F2022			F2021			Amt.		Pct.
Revenues	$	69.0		$	40.2		$	28.9	71.9	%	$	121.7		$	68.3		$	53.4	78.2	%
Operating income (loss)	6.8			(2.2)			9.1		404.5	%	3.8			(7.9)			11.8		149.4	%
Operating margin (% of revenues)	9.9		%	(5.6)		%					3.2		%	(11.6)		%

Our hotels and resorts division operating income during the second quarter and first half of fiscal 2022 increased compared to operating losses in the second quarter and first half of fiscal 2021, due to significantly increased revenues during the fiscal 2022 periods. All of our company-owned hotels and resorts contributed to the improved operating results during the second quarter of fiscal 2022, and all but one of our company-owned hotels and resorts contributed to the improved operating results during the first half of fiscal 2022 compared to the fiscal 2021 periods.

22

The following table provides a further breakdown of the components of revenues for the hotels and resorts division for the second quarter and first half of fiscal 2022 and fiscal 2021 (in millions, except for variance percentage):

	Second Quarter								First Half
					Variance								Variance
	F2022		F2021		Amt.		Pct.		F2022		F2021		Amt.		Pct.
Room revenues	$	28.9	$	17.3	$	11.5	66.5	%	$	46.3	$	26.4	$	19.9	75.4	%
Food/beverage revenues	19.0		9.6		9.4		98.2	%	33.5		15.5		18.0		116.1	%
Other revenues	12.9		9.9		3.0		30.6	%	26.0		19.7		6.2		31.5	%
	60.8		36.8		24.0		65.2	%	105.8		61.6		44.2		71.8	%
Cost reimbursements	8.3		3.4		4.9		144.6	%	15.9		6.7		9.2		137.3	%
Total revenues	$	69.0	$	40.2	$	28.9	71.9	%	$	121.7	$	68.3	$	53.4	78.2	%

Division revenues increased significantly during the second quarter and first half of fiscal 2022 compared to the second quarter and first half of fiscal 2021. While all eight of our company-owned hotels and all but one of our managed hotels were open during the second quarter and first half of fiscal 2021, the majority of these properties were generating significantly reduced revenues and operating under applicable state and local restrictions and guidelines, and, in some cases, reduced operating hours. In addition, we reopened our Milwaukee SafeHouse restaurant and bar in June 2021 and reopened the Chicago SafeHouse in May 2022.

We believe it is also beneficial to compare our revenues to pre-pandemic levels. The following table compares the components of revenues for the hotels and resorts division for the second quarter and first half of fiscal 2022 to the second quarter and first half of fiscal 2019 (in millions, except for variance percentage):

	Second Quarter								First Half
					Variance								Variance
	F2022		F2019		Amt.		Pct.		F2022		F2019		Amt.		Pct.
Room revenues	$	28.9	$	28.2	$	0.7	2.4	%	$	46.3	$	47.1	$	(0.8)	(1.7)	%
Food /beverage revenues	19.0		18.6		0.4		2.1	%	33.5		34.4		(0.9)		(2.6)	%
Other revenues	12.9		11.2		1.7		14.8	%	26.0		23.4		2.6		11.1	%
	60.8		58.0		2.7		4.7	%	105.8		104.9		0.9		0.9	%
Cost reimbursements	8.3		11.9		(3.7)		(30.9)	%	15.9		20.1		(4.3)		(21.4)	%
Total revenues	$	69.0	$	70.0	$	(1.0)	(1.4)	%	$	121.7	$	125.0	$	(3.4)	(2.7)	%

Leisure travel continued to drive demand during the second quarter and first half of fiscal 2022, representing an increased percentage of total rooms revenues compared to the fiscal 2019 periods. The leisure travel increase offset lower transient and group business revenues during the second quarter and first half of fiscal 2022 compared to the same quarter and half of fiscal 2019. A decrease in group business subsequently led to a corresponding decrease in banquet and catering revenues, negatively impacting our reported food and beverage revenues in the first half of fiscal 2022 compared to the first half of fiscal 2019. Other revenues increased during the second quarter and first half of fiscal 2022 compared to the second quarter and first half of fiscal 2019, primarily due to increased revenues from one of our condominium hotels and increased ski and spa revenues at the Grand Geneva® Resort & Spa (“Grand Geneva”), partially offset by decreased management fees. Cost reimbursements decreased during the second quarter and first half of fiscal 2022 compared to the second quarter and first half of fiscal 2019 due to a lower number of managed hotels and reduced revenues and subsequent operating costs at our managed hotels.

The following table sets forth certain operating statistics for the second quarter and first half of fiscal 2022 and fiscal 2021, including our average occupancy percentage (number of occupied rooms as a percentage of available rooms), our average daily room rate, or ADR, and our total revenue per available room, or RevPAR, for company-owned properties:

23

	Second Quarter										First Half
							Variance										Variance
	F2022			F2021			Amt.		Pct.		F2022			F2021			Amt.		Pct.
Occupancy pct.	66.3		%	48.8		%	17.5 pts		35.9	%	57.2		%	37.9		%	19.3 pts		50.8	%
ADR	$	177.87		$	143.37		$	34.50	24.1	%	$	164.95		$	139.73		$	25.22	18.0	%
RevPAR	$	118.00		$	69.99		$	48.01	68.6	%	$	94.29		$	52.93		$	41.36	78.1	%

Note: These operating statistics represent averages of our eight distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort. The statistics exclude days during fiscal 2021 where individual hotels may have been closed.

RevPAR increased at all eight of our company-owned properties during the second quarter and first half of fiscal 2022 compared to the second quarter and first half of fiscal 2021. Leisure travel customers provided the most demand during the fiscal 2022 second quarter, with weekend business relatively strong at the majority of our properties. During the second quarter of fiscal 2022, our non-group business represented approximately 63% of our total rooms revenue, compared to approximately 57% during the second quarter of fiscal 2019 prior to the pandemic. Although group business continues to lag prior years, it has sequentially increased each quarter during fiscal 2022. Non-group retail pricing was very strong in the majority of our markets, with significant leisure demand contributing to increased occupancy percentages and ADR.

We believe it is also beneficial to compare our operating statistics to pre-pandemic levels. The following table sets forth certain operating statistics for the second quarter and first half of fiscal 2022 and fiscal 2019, including our average occupancy percentage, our ADR, and our RevPAR, for company-owned properties:

	Second Quarter										First Half
							Variance										Variance
	F2022			F2019			Amt.		Pct.		F2022			F2019			Amt.		Pct.
Occupancy pct.	66.8		%	77.9		%	(11.2) pts		(14.3)	%	57.8		%	71.2		%	(13.4) pts		(18.8)	%
ADR	$	174.98		$	160.10		$	14.88	9.3	%	$	162.29		$	146.47		$	15.82	10.8	%
RevPAR	$	116.81		$	124.67		$	(7.86)	(6.3)	%	$	93.88		$	104.36		$	(10.48)	(10.0)	%

Note: These operating statistics represent averages of our seven distinct comparable company-owned hotels and resorts, branded and unbranded, in different geographic markets with a wide range of individual hotel performance. The statistics are not necessarily representative of any particular hotel or resort. The statistics for both the 2022 and 2019 periods exclude the Saint Kate, which was closed during the majority of the fiscal 2019 periods presented.

According to data received from Smith Travel Research and compiled by us in order to evaluate our fiscal 2022 second quarter and first half results, comparable “upper upscale” hotels—hotels identified as our industry— throughout the United States experienced an increase in RevPAR of 0.8% during our fiscal 2022 second quarter and a decrease in RevPAR of 7.7% during our fiscal 2022 first half compared to the same periods during fiscal 2019, leading us to believe we underperformed the industry during the fiscal 2022 second quarter and first half by approximately 7 and 2 percentage points, respectively. We believe this underperformance results from the customer mix shift described above with an increase in the percentage of group business at lower daily rates and a decrease in the percentage of leisure customers at higher daily rates. While this shift is unfavorable to RevPAR, the higher mix of group business results in a corresponding increase in food and beverage revenues. We also believe leisure travel remains stronger in other U.S. markets and “fly-to” destinations in which we do not have a presence, which contributed to our underperformance.

Data received from Smith Travel Research for our various “competitive sets”—hotels identified in our specific markets that we deem to be competitors to our hotels—indicates that these hotels experienced a decrease in RevPAR of 9.0% and 14.0% during our second quarter and first half of fiscal 2022, again compared to the same periods in fiscal 2019. Therefore, we believe we outperformed our competitive sets during the second quarter and first half of fiscal 2022 by approximately 3 and 4 percentage points, respectively. Higher class segments of the hotel industry, such as luxury and upper upscale (with an increased reliance on business travel), continue to experience lower occupancies compared to lower class hotel segments such as economy and midscale.

Looking to future periods, overall occupancy in the U.S. continues to slowly increase, in recent months reaching its highest level since the start of the pandemic. In the near term, we expect most demand will continue to come from the leisure travel

24

segment. Leisure travel in our markets has a seasonal component, peaking in the summer months and slowing down as children return to school and the weather turns colder. We are experiencing increases in business travel as corporate training events, meetings, and conferences return and downtown offices reopen. Our company-owned hotels have experienced a decrease in group bookings compared to pre-pandemic periods. As of the date of this report, our group room revenue bookings for fiscal 2022 - commonly referred to in the hotels and resorts industry as “group pace” - is running approximately 8% behind where we were at the same time in fiscal 2019, but despite our reduced group pace as compared to the second quarter of fiscal 2019, our current group pace is an improvement from recent quarters and we are experiencing increased booking activity for fiscal 2022 and 2023 and beyond. Banquet and catering revenue pace for fiscal 2022 is also running behind where we were at the same time in fiscal 2019, but not as much as group pace, due in part to increases in corporate group, event and wedding bookings. Overall, we generally expect our revenue trends to track or exceed the overall industry trends for our segment of the industry, particularly in our respective markets.

Adjusted EBITDA

Adjusted EBITDA is a measure used by management and our board of directors to assess our financial performance and enterprise value. We believe that Adjusted EBITDA is a useful measure for us and investors, as it eliminates certain expenses that are not indicative of our core operating performance and facilitates a comparison of our core operating performance on a consistent basis from period to period. We also use Adjusted EBITDA as a basis to determine certain annual cash bonuses and long-term incentive awards, to supplement GAAP measures of performance to evaluate the effectiveness of our business strategies, to make budgeting decisions, and to compare our performance against that of other peer companies using similar measures. Adjusted EBITDA is also used by analysts, investors and other interested parties as a performance measure to evaluate industry competitors.

Adjusted EBITDA is a non-GAAP measure of our financial performance and should not be considered as an alternative to net earnings (loss) as a measure of financial performance, or any other performance measure derived in accordance with GAAP. Additionally, Adjusted EBITDA is not intended to be a measure of liquidity or free cash flow for management’s discretionary use. Adjusted EBITDA has its limitations as an analytical tool, and you should not consider it in isolation or as a substitute for analysis of our results as reported under GAAP.

We define Adjusted EBITDA as net earnings (loss) attributable to The Marcus Corporation before investment income or loss, interest expense, other expense, gain or loss on disposition of property, equipment and other assets, equity earnings or losses from unconsolidated joint ventures, net earnings or losses attributable to noncontrolling interests, income taxes and depreciation and amortization, adjusted to eliminate the impact of certain items that we do not consider indicative of our core operating performance. These further adjustments are itemized below. You are encouraged to evaluate these adjustments and the reasons we consider them appropriate for supplemental analysis. In evaluating Adjusted EBITDA, you should be aware that in the future we will incur expenses that are the same as or similar to some of the items eliminated in the adjustments made to determine Adjusted EBITDA, such as acquisition expenses, preopening expenses, accelerated depreciation, impairment charges and other adjustments. Our presentation of Adjusted EBITDA should not be construed to imply that our future results will be unaffected by any such adjustments. Definitions and calculations of Adjusted EBITDA differ among companies in our industries, and therefore Adjusted EBITDA disclosed by us may not be comparable to the measures disclosed by other companies.

25

The following table sets forth our reconciliation of Adjusted EBITDA (in millions):

	Second Quarter				First Half
	F2022		F2021		F2022		F2021
Net earnings (loss) attributable to The Marcus Corporation	$	9.0	$	(23.4)	$	(5.9)	$	(51.5)
Add (deduct):
Investment (income) loss	0.5		(0.1)		0.7		(0.2)
Interest expense	4.1		4.9		8.2		9.8
Other expense	0.6		0.6		1.2		1.3
Loss (gain) on disposition of property, equipment and other assets	0.1		0.2		(0.4)		(2.0)
Equity (earnings) losses from unconsolidated joint ventures	—		—		0.1		—
Income tax expense (benefit)	4.8		(8.3)		(1.8)		(19.1)
Depreciation and amortization	16.8		18.5		34.0		36.5
Share-based compensation expenses (1)	1.7		2.7		4.6		4.2
Impairment charges (2)	—		3.7		—		3.7
Government grants (3)	—		—		—		(1.3)
Total Adjusted EBITDA	$	37.3	$	(1.2)	$	40.7	$	(18.7)

The following tables sets forth our reconciliation of Adjusted EBITDA by reportable operating segment (in millions):

	Second Quarter, F2022								First Half, F2022
	Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total
Operating income (loss)	$	16.4	$	6.8	$	(4.4)	$	18.9	$	8.4	$	3.8	$	(10.2)	2.1
Depreciation and amortization	11.9		4.8		0.1		16.8		24.1		9.8		0.2		34.0
Share-based compensation (1)	0.5		0.2		1.0		1.7		1.1		0.6		2.9		4.6
Total Adjusted EBITDA	$	28.8	$	11.8	$	(3.3)	$	37.3	$	33.5	$	14.2	(7.1)		40.7

	Second Quarter, F2021								First Half, F2021
	Theatres		Hotels & Resorts		Corp. Items		Total		Theatres		Hotels & Resorts		Corp. Items		Total
Operating loss	$	(18.2)	$	(2.2)	$	(5.7)	$	(26.1)	$	(43.9)	$	(7.9)	$	(10.0)	(61.8)
Depreciation and amortization	13.4		5.0		0.1		18.5		26.2		10.2		0.1		36.5
Share-based compensation (1)	0.7		0.5		1.5		2.7		1.1		0.8		2.3		4.2
Impairment charges (2)	3.7		—		—		3.7		3.7		—		—		3.7
Government grants (3)	—		—		—		—		(1.3)		—		—		(1.3)
Total Adjusted EBITDA	$	(0.4)	$	3.3	$	(4.1)	$	(1.2)	$	(14.2)	$	3.0	(7.6)		(18.7)

(1)Non-cash expense related to share-based compensation programs.

(2)Non-cash impairment charges related to surplus theatre real estate.

(3)Reflects a nonrecurring state government grant awarded to our theatres for COVID-19 pandemic relief.

26

The following table sets forth Adjusted EBITDA by reportable operating segment for the second quarter and first half of fiscal 2022 and fiscal 2021 (in millions, except for variance percentage):

	Second Quarter								First Half
					Variance								Variance
	F2022		F2021		Amt.		Pct.		F2022		F2021		Amt.		Pct.
Theatres	$	28.8	$	(0.4)	$	29.2	6620.0	%	$	33.5	$	(14.2)	$	47.7	336.6	%
Hotels and resorts	11.8		3.3		8.5		255.0	%	14.2		3.0		11.2		368.0	%
Corporate items	(3.3)		(4.1)		0.8		20.0	%	(7.1)		(7.6)		0.5		6.0	%
Total Adjusted EBITDA	$	37.3	$	(1.2)	$	38.5	3167.4	%	$	40.7	$	(18.7)	$	59.3	317.6	%

During the second quarter of fiscal 2022, our theatre division reported its fourth straight quarter with positive Adjusted EBITDA since the start of the COVID-19 pandemic due to increased attendance and increased revenues per person, as described in the Theatres section above. During the second quarter of fiscal 2022, our hotels and resorts division reported its fifth straight quarter with positive Adjusted EBITDA due to improved occupancy percentages and ADR, and strong cost controls, as described in the Hotels and Resorts section above. Our second quarter of fiscal 2022 is our fourth straight quarter with consolidated positive Adjusted EBITDA since the start of the pandemic.

LIQUIDITY AND CAPITAL RESOURCES

Liquidity

Our movie theatre and hotels and resorts businesses, when open and operating normally, each generate significant and consistent daily amounts of cash, subject to previously-noted seasonality, because each segment’s revenue is derived predominantly from consumer cash purchases. Under normal circumstances, we believe that these relatively consistent and predictable cash sources, as well as the availability of unused credit lines, would be adequate to support the ongoing operational liquidity needs of our businesses.

Maintaining and protecting a strong balance sheet has always been a core value of The Marcus Corporation during our 87-year history, and, despite the COVID-19 pandemic, our financial position remains strong. As of June 30, 2022, we had a cash balance of approximately $57.7 million, $221.8 million of availability under our $225 million revolving credit facility, and our debt-to-capitalization ratio (including short-term borrowings) was 0.37. With our strong liquidity position, combined with cash generated from operations and proceeds from the sale of surplus real estate (discussed above), we believe we are positioned to meet our obligations as they come due and continue to sustain our operations throughout fiscal 2022 and fiscal 2023, even if our properties continue to generate reduced revenues during these periods. We will continue to work to preserve cash and maintain strong liquidity to endure the impacts of the global pandemic, even if it continues for a prolonged period of time.

We believe that the actions we have taken during the past two years will allow us to have sufficient liquidity to meet our obligations as they come due and to comply with our debt covenants for at least 12 months from the issuance date of the consolidated financial statements. However, future compliance with our debt covenants could be impacted if we are unable to continue operations as currently expected, which could be impacted by matters that are not entirely in our control, such as the reinstatement of protective actions that federal, state and local governments have taken and the timing of new movie releases (as described in the Impact of the COVID-19 Pandemic section of this MD&A and in our Annual Report for the year ended December 30, 2021). Future compliance with our debt covenants could also be impacted if the speed of recovery of our theatres and hotels and resorts businesses is slower than currently expected. For example, our current expectations are that our theatre division will continue to improve during the fiscal 2022 (but still report results below comparable periods in fiscal 2019), before beginning to progressively return to closer-to-normal performance in fiscal 2023. Our current expectations for our hotels and resorts division are that we will continue to show improvement in each succeeding quarter compared to the prior year. We do not expect to return to pre-COVID-19 occupancy levels during fiscal 2022 due to an expected lag in business travel. It is possible that the impact of COVID-19 may be greater than currently expected across one or both of our divisions such that we may be unable to comply with our debt covenants in future periods. In such an event, we would either seek covenant waivers or attempt to amend our covenants, though there is no certainty that we would be successful in such efforts.

27

Financial Condition

Net cash provided by operating activities totaled $55.2 million during the first half of fiscal 2022, compared to net cash used in operating activities of $9.7 million during the first half of fiscal 2021. The $64.9 million increase in net cash provided by operating activities was due primarily to a reduced net loss and the favorable timing in the collection of accounts receivable and receipt of refundable income taxes of $22.7 million, partially offset by unfavorable timing in the payment of accounts payable, accrued compensation and other accrued liabilities during the first half of fiscal 2022.

Net cash used in investing activities during the first half of fiscal 2022 totaled $11.5 million, compared to net cash used in investing activities of $3.7 million during the first half of fiscal 2021. The increase in net cash used in investing activities of $7.7 million was the result of an increase of $10.1 million in capital expenditures. Total cash capital expenditures (including normal continuing capital maintenance and renovation projects) totaled $16.3 million during the first half of fiscal 2022 compared to $6.2 million during the first half of fiscal 2021.

Fiscal 2022 first half cash capital expenditures included approximately $5.0 million incurred in our theatre division, primarily related to normal maintenance capital projects. We also incurred capital expenditures in our hotels and resorts division during the first half of fiscal 2022 of approximately $11.3 million, including costs related to rooms renovations at the Grand Geneva and normal maintenance capital projects.

Net cash used in financing activities during the first half of fiscal 2022 totaled $4.4 million compared to net cash provided by financing activities of $14.5 million during the first half of fiscal 2021. During the first half of fiscal 2022, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As short-term revolving credit facility borrowings became due, we replaced them as necessary with new short-term revolving credit facility borrowings. As a result, we added $22.0 million of new short-term revolving credit facility borrowings, and we made $22.0 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2022 (net zero borrowings on our credit facility). We ended the second quarter of fiscal 2022 with no outstanding borrowings under our revolving credit facility. During the first half of fiscal 2021, we increased our borrowings under our revolving credit facility as needed to fund our cash needs and used excess cash to reduce our borrowings under our revolving credit facility. As a result, we added $66.5 million of new short-term revolving credit facility borrowings, and we made $46.5 million of repayments on short-term revolving credit facility borrowings during the first half of fiscal 2021 (net increase in borrowings on our credit facility of $20.0 million).

During the first half of fiscal 2022 we repaid $0.8 million of short-term term loan borrowings, compared to $4.2 million of such repayments during the first half of fiscal 2021. Principal payments on long-term debt were approximately $0.9 million during the first half of fiscal 2022 compared to payments of $0.2 million during the first half of fiscal 2021. Our debt-to-capitalization ratio (including short-term borrowings but excluding our finance and operating lease obligations) was 0.37 at June 30, 2022, compared to 0.37 at December 30, 2021.

Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022 we repaid $46.6 million of short-term borrowings, repaying in full and retiring the term loan facility maturing on September 22, 2022. In connection with the repayment of the term loan, the Company amended the Credit Agreement by entering into the Fourth Amendment which modified the consolidated fixed charge coverage covenant, reducing the requirement to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 to at least 2.5 to 1.0 starting as of the end of the fiscal quarter ending March 30, 2023 and continuing for each fiscal quarter thereafter.

During the first half of fiscal 2022 and the first half of fiscal 2021 we did not repurchase any shares of our common stock in the open market. As of June 30, 2022, approximately 2.6 million shares remained available for repurchase under prior Board of Directors repurchase authorizations. Under these authorizations, we may repurchase shares of our common stock from time to time in the open market, pursuant to privately-negotiated transactions or otherwise, depending upon a number of factors, including prevailing market conditions.

We did not make any dividend payments during the first half of fiscal 2022 and the first half of fiscal 2021. Our Credit Agreement, as amended, required us to temporarily suspend our quarterly dividend payments and prohibited us from repurchasing shares of our common stock in the open market during fiscal 2021. The Credit Agreement also limits the total amount of quarterly dividend payments or share repurchases during the four subsequent quarters beginning with the first quarter of fiscal 2022 to no more than $1.55 million per quarter, unless we are in compliance with prior financial covenants under the Credit Agreement (specifically, the consolidated fixed charge coverage ratio), at which point we have the ability

28

to declare quarterly dividend payments and/or repurchase shares of our common stock in the open market as we deem appropriate.

Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022 the Board of Directors declared a regular quarterly cash dividend of $0.05 per share of common stock. The dividend will be paid September 15, 2022 to shareholders of record on August 25, 2022. The Board of Directors also declared a dividend of $0.045 per share on the Class B common stock. The dividend on the Class B common stock, which is not publicly traded, will also be paid September 15, 2022 to shareholders of record on August 25, 2022.

Item 3. Quantitative and Qualitative Disclosures about Market Risk

We have not experienced any material changes in our market risk exposures since December 30, 2021.

Item 4. Controls and Procedures

a.Evaluation of disclosure controls and procedures

Based on their evaluations and the evaluation of management, as of the end of the period covered by this Quarterly Report on Form 10-Q, our principal executive officer and principal financial officer have concluded that our disclosure controls and procedures (as defined in Rules 13a-15 and 15d-15 under the Securities Exchange Act of 1934 (the “Exchange Act”)) are effective to ensure that information required to be disclosed by us in reports that we file or submit under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in Securities and Exchange Commission rules and forms.

b.Changes in internal control over financial reporting

There were no significant changes in our internal control over financial reporting identified in connection with the evaluation required by Rule 13a-15 of the Exchange Act that occurred during the period covered by this Quarterly Report on Form 10-Q that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

29

PART II – OTHER INFORMATION

Item 1A. Risk Factors

There have been no material changes from the risk factors disclosed in the Company’s Annual Report on Form 10-K for the year ended December 30, 2021.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds

The following table sets forth information with respect to purchases made by us or on our behalf of our Common Stock during the periods indicated.

Period	Total Number of Shares Purchased	Average Price Paid per Share		Total Number of Shares Purchased as Part of Publicly Announced Programs (1)	Maximum Number of Shares that May Yet be Purchased Under the Plans or Programs (1)
April 1 - April 28	—	$	—	—	2,581,495
April 29 - June 2	6,973	14.86		6,973	2,574,522
June 3 - June 30	55	14.91		55	2,574,467
Total	7,028	$	14.86	7,028	2,574,467

(1)Through June 30, 2022, our Board of Directors had authorized the repurchase of up to approximately 11.7 million shares of our outstanding Common Stock. Under these authorizations, we may repurchase shares of our Common Stock from time to time in the open market, pursuant to privately negotiated transactions or otherwise. As of June 30, 2022, we had repurchased approximately 9.1 million shares of our Common Stock under these authorizations. The repurchased shares are held in our treasury pending potential future issuance in connection with employee benefit, option or stock ownership plans or other general corporate purposes. These authorizations do not have an expiration date. The shares purchased during the second quarter of 2022 were purchased in connection with the vesting of grants of restricted stock, in which we repurchased shares from the stockholders whose restricted shares vested in order to cover such stockholders’ related withholding taxes.

Item 4. Mine Safety Disclosures

Not applicable.

Item 6. Exhibits

31.1	Certification by the Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
31.2	Certification by the Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.
32	Written Statement of the Chief Executive Officer and Chief Financial Officer pursuant to 18 U.S.C. §1350.
101.INS	The instance document does not appear in the interactive data file because its XBRL (Extensible Business Reporting Language) tags are embedded within the Inline XBRL document.
101.SCH	Inline XBRL Taxonomy Extension Schema Document.
101.CAL	Inline XBRL Taxonomy Extension Calculation Linkbase Document.
101.DEF	Inline XBRL Taxonomy Extension Definition Linkbase Document.
101.LAB	Inline XBRL Taxonomy Extension Label Linkbase Document.
101.PRE	Inline XBRL Taxonomy Extension Presentation Linkbase Document
104	Cover Page Interactive Data File (embedded within the Inline XBRL document).

30

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

THE MARCUS CORPORATION
DATE: August 4, 2022	By:	/s/ Gregory S. Marcus
		Gregory S. Marcus
		President and Chief Executive Officer
DATE: August 4, 2022	By:	/s/ Chad M. Paris
		Chad M. Paris
		Chief Financial Officer and Treasurer

S-1

EX-31.1

Exhibit 31.1

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a)

or 15d-14(a) under the Securities Exchange Act of 1934

I, Gregory S. Marcus, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of The Marcus Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

DATE: August 4, 2022	By:	/s/ Gregory S. Marcus
		Gregory S. Marcus
		President and Chief Executive Officer

EX-31.2

Exhibit 31.2

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act and Rule 13a-14(a)

or 15d-14(a) under the Securities Exchange Act of 1934

I, Chad M. Paris, certify that:

1.I have reviewed this Quarterly Report on Form 10-Q of The Marcus Corporation;

2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting.

5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

DATE: August 4, 2022	By:	/s/ Chad M. Paris
		Chad M. Paris
		Chief Financial Officer and Treasurer

EX-32

Exhibit 32

Written Statement of the Chief Executive Officer and Chief Financial Officer

Pursuant to 18 U.S.C. §1350

Solely for the purposes of complying with 18 U.S.C. §1350, we, the undersigned Chief Executive Officer and Chief Financial Officer of The Marcus Corporation (the “Company”), hereby certify, based on our knowledge, that the accompanying Quarterly Report on Form 10-Q of the Company (the “Report”) fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

/s/ Gregory S. Marcus
Gregory S. Marcus
President and Chief Executive Officer
/s/ Chad M. Paris
Chad M. Paris
Chief Financial Officer and Treasurer
Date:	August 4, 2022

XML

Cover - shares	6 Months Ended
	Jun. 30, 2022	Aug. 01, 2022
Document Information [Line Items]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Jun. 30, 2022
Document Transition Report	false
Entity File Number	1-12604
Entity Registrant Name	MARCUS CORP
Entity Incorporation, State or Country Code	WI
Entity Tax Identification Number	39-1139844
Entity Address, Address Line One	100 East
Entity Address, Address Line Two	Wisconsin Avenue
Entity Address, Address Line Three	Suite 1900
Entity Address, City or Town	Milwaukee
Entity Address, State or Province	WI
Entity Address, Postal Zip Code	53202-4125
City Area Code	414
Local Phone Number	905-1000
Title of 12(b) Security	Common Stock, $1.00 par value
Trading Symbol	MCS
Security Exchange Name	NYSE
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Central Index Key	0000062234
Current Fiscal Year End Date	--12-29
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q2
Amendment Flag	false
Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		24,395,412
Class B Common Stock
Document Information [Line Items]
Entity Common Stock, Shares Outstanding		7,110,875

XML

Consolidated Balance Sheets - USD ($)	Jun. 30, 2022	Dec. 30, 2021
Current assets:
Cash and cash equivalents	$ 57,741,000	$ 17,658,000
Restricted cash	5,677,000	6,396,000
Accounts receivable, net of reserves of $169 and $1,001, respectively	26,273,000	28,902,000
Government grants receivable	0	4,335,000
Refundable income taxes	0	22,435,000
Assets held for sale	521,000	4,856,000
Other current assets	19,683,000	15,364,000
Total current assets	109,895,000	99,946,000
Property and equipment:
Land and improvements	129,802,000	129,642,000
Buildings and improvements	766,057,000	756,974,000
Leasehold improvements	167,316,000	166,060,000
Furniture, fixtures and equipment	383,997,000	375,650,000
Finance lease right-of-use assets	75,262,000	75,124,000
Construction in progress	3,652,000	6,000,000
Total property and equipment	1,526,086,000	1,509,450,000
Less accumulated depreciation and amortization	770,460,000	738,258,000
Net property and equipment	755,626,000	771,192,000
Operating lease right-of-use assets	209,264,000	217,072,000
Other assets:
Investments in joint ventures	2,202,000	2,335,000
Goodwill	75,052,000	75,095,000
Deferred incomes taxes	10,198,000	10,032,000
Other	12,398,000	12,689,000
Total other assets	99,850,000	100,151,000
TOTAL ASSETS	1,174,635,000	1,188,361,000
Current liabilities:
Accounts payable	38,335,000	35,781,000
Income taxes	283,000	0
Taxes other than income taxes	19,219,000	19,566,000
Accrued compensation	18,879,000	20,474,000
Other accrued liabilities	59,334,000	59,678,000
Short-term borrowings	46,628,000	47,346,000
Current portion of finance lease obligations	2,489,000	2,561,000
Current portion of operating lease obligations	16,291,000	16,795,000
Current maturities of long-term debt	11,077,000	10,967,000
Total current liabilities	212,535,000	213,168,000
Finance lease obligations	16,116,000	17,192,000
Operating lease obligations	207,713,000	216,064,000
Long-term debt	203,720,000	204,177,000
Deferred income taxes	25,125,000	26,183,000
Other long-term obligations	56,693,000	57,963,000
Shareholders’ equity attributable to The Marcus Corporation
Preferred Stock, $1 par; authorized 1,000,000 shares; none issued	0	0
Capital in excess of par	150,565,000	145,656,000
Retained earnings	283,364,000	289,306,000
Accumulated other comprehensive loss	(10,529,000)	(11,444,000)
Stockholders' equity before treasury stock	455,009,000	454,993,000
Less cost of Common Stock in treasury (112,282 shares at June 30, 2022 and 48,111 shares at December 30, 2021)	(2,276,000)	(1,379,000)
Total shareholders’ equity attributable to The Marcus Corporation	452,733,000	453,614,000
Noncontrolling interest	0	0
Total equity	452,733,000	453,614,000
TOTAL LIABILITIES AND SHAREHOLDERS’ EQUITY	1,174,635,000	1,188,361,000
Common Stock
Shareholders’ equity attributable to The Marcus Corporation
Common Stock	24,498,000	24,345,000
Class B Common Stock
Shareholders’ equity attributable to The Marcus Corporation
Common Stock	$ 7,111,000	$ 7,130,000

XML

Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 30, 2021
Accounts receivable, reserves	$ 169	$ 1,001
Preferred stock, par (in dollars per share)	$ 1	$ 1
Preferred stock, authorized (in shares)	1,000,000	1,000,000
Preferred stock, issued (in shares)	0	0
Cost of common stock in treasury (in shares)	112,282	48,111
Common Stock
Common stock, par (in dollars per share)	$ 1	$ 1
Common stock, authorized (in shares)	50,000,000	50,000,000
Common stock, issued (in shares)	24,498,243	24,345,356
Class B Common Stock
Common stock, par (in dollars per share)	$ 1	$ 1
Common stock, authorized (in shares)	33,000,000	33,000,000
Common stock, issued (in shares)	7,110,875	7,130,125
Common stock, outstanding (in shares)	7,110,875	7,130,125

XML

Consolidated Statements of Earnings (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Revenues:
Revenues	$ 190,305	$ 89,130	$ 314,934	$ 136,584
Cost reimbursements	8,250	3,417	15,863	6,750
Total revenues	198,555	92,547	330,797	143,334
Costs and expenses:
Advertising and marketing	5,978	3,819	10,459	6,368
Administrative	17,627	15,963	36,708	29,279
Depreciation and amortization	16,752	18,494	33,983	36,473
Rent	6,578	6,344	12,828	12,685
Property taxes	4,980	4,468	9,725	9,207
Other operating expenses	9,261	8,628	18,935	13,418
Impairment charges	0		0	3,732
Reimbursed costs	8,250	3,417	15,863	6,750
Total costs and expenses	179,662	118,657	328,701	205,105
Operating income (loss)	18,893	(26,110)	2,096	(61,771)
Other income (expense):
Investment income (loss)	(459)	120	(727)	160
Interest expense	(4,063)	(4,907)	(8,155)	(9,750)
Other expense	(584)	(628)	(1,161)	(1,256)
Gain (loss) on disposition of property, equipment and other assets	(69)	(164)	355	2,040
Equity earnings ( losses) from unconsolidated joint ventures	7	0	(134)	0
Nonoperating income (expense), total	(5,168)	(5,579)	(9,822)	(8,806)
Earnings (loss) before income taxes	13,725	(31,689)	(7,726)	(70,577)
Income tax expense ( benefit)	4,765	(8,323)	(1,784)	(19,081)
Net earnings (loss)	8,960	(23,366)	(5,942)	(51,496)
Net earnings (loss) attributable to noncontrolling interests	0	0	0	0
Net earnings (loss) attributable to The Marcus Corporation	$ 8,960	$ (23,366)	$ (5,942)	$ (51,496)
Common Stock
Net earnings (loss) per share - basic:
Common stock (in dollars per share)	$ 0.29	$ (0.76)	$ (0.19)	$ (1.71)
Net earnings (loss) per share - diluted:
Common stock (in dollars per share)	0.24	(0.76)	(0.19)	(1.71)
Class B Common Stock
Net earnings (loss) per share - basic:
Common stock (in dollars per share)	0.26	(0.68)	(0.18)	(1.44)
Net earnings (loss) per share - diluted:
Common stock (in dollars per share)	$ 0.23	$ (0.68)	$ (0.18)	$ (1.44)
Theatre admissions
Revenues:
Revenues	$ 63,087	$ 24,915	$ 101,504	$ 35,600
Rooms
Revenues:
Revenues	28,865	17,332	46,295	26,376
Costs and expenses:
Costs	10,471	7,072	18,674	12,337
Theatre concessions
Revenues:
Revenues	58,147	23,061	93,611	32,980
Costs and expenses:
Costs	22,993	10,037	38,186	14,533
Food and beverage
Revenues:
Revenues	19,014	9,591	33,525	15,503
Costs and expenses:
Costs	15,035	7,806	27,175	13,176
Other revenues
Revenues:
Revenues	21,192	14,231	39,999	26,125
Theatre operations
Costs and expenses:
Costs	$ 61,737	$ 28,877	$ 106,165	$ 47,147

XML

Consolidated Statements of Comprehensive Income (Loss) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Statement of Comprehensive Income [Abstract]
Net earnings (loss)	$ 8,960	$ (23,366)	$ (5,942)	$ (51,496)
Other comprehensive income (loss), net of tax:
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect of $67, $86, $134 and $172 , respectively	190	242	380	484
Fair market value adjustment of interest rate swap, net of tax effect (benefit) of $37, $(2), $116 and $4, respectively	106	(7)	329	10
Reclassification adjustment on interest rate swap included in interest expense, net of tax effect of $31, $43, $72 and $111, respectively	88	121	206	314
Other comprehensive income	384	356	915	808
Comprehensive income (loss)	9,344	(23,010)	(5,027)	(50,688)
Comprehensive earnings (loss) attributable to noncontrolling interests	0	0	0	0
Comprehensive income (loss) attributable to The Marcus Corporation	$ 9,344	$ (23,010)	$ (5,027)	$ (50,688)

XML

Consolidated Statements of Comprehensive Income (Loss) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Statement of Comprehensive Income [Abstract]
Amortization of the net actuarial loss and prior service credit related to the pension, net of tax effect	$ 67	$ 86	$ 134	$ 172
Fair market value adjustment of interest rate swap, net of tax effect	37	(2)	116	4
Reclassification adjustment related to interest rate swap de-designation, net of tax effect	$ 31	$ 43	$ 72	$ 111

XML

Consolidated Statements of Cash Flows - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021
OPERATING ACTIVITIES:
Net loss	$ (5,942)	$ (51,496)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:
Losses on investments in joint ventures	134	0
Gain on disposition of property, equipment and other assets	(355)	(2,040)
Impairment charges	0	3,732
Depreciation and amortization	33,983	36,473
Amortization of debt issuance costs	826	1,244
Share-based compensation	4,572	4,152
Deferred income taxes	(1,505)	(19,181)
Other long-term obligations	(49)	1,180
Contribution of the Company’s stock to savings and profit-sharing plan	956	1,012
Changes in operating assets and liabilities:
Accounts receivable	2,629	(4,944)
Government grants receivable	4,335	4,913
Other assets	(4,294)	(1,712)
Operating leases	(1,047)	(2,484)
Accounts payable	551	6,369
Income taxes	22,720	6,003
Taxes other than income taxes	(347)	(654)
Accrued compensation	(1,595)	6,650
Other accrued liabilities	(344)	1,102
Total adjustments	61,170	41,815
Net cash provided by (used in) operating activities	55,228	(9,681)
INVESTING ACTIVITIES:
Capital expenditures	(16,341)	(6,195)
Proceeds from disposals of property, equipment and other assets	4,821	4,297
Purchase of trading securities	0	(1,906)
Other investing activities	45	59
Net cash used in investing activities	(11,475)	(3,745)
Debt transactions:
Proceeds from borrowings on revolving credit facility	22,000	66,500
Repayment of borrowings on revolving credit facility	(22,000)	(46,500)
Repayments on short-term borrowings	(820)	(4,150)
Principal payments on long-term debt	(851)	(187)
Debt issuance costs	0	(4)
Principal payments on finance lease obligations	(1,336)	(1,329)
Equity transactions:
Treasury stock transactions, except for stock options	(1,461)	(1,236)
Exercise of stock options	79	1,374
Net cash (used in) provided by financing activities	(4,389)	14,468
Net increase in cash, cash equivalents and restricted cash	39,364	1,042
Cash, cash equivalents and restricted cash at beginning of period	24,054	14,088
Cash, cash equivalents and restricted cash at end of period	63,418	15,130
Supplemental Information:
Interest paid, net of amounts capitalized	7,054	7,719
Income taxes refunded, including interest earned	22,998	5,910
Change in accounts payable for additions to property, equipment and other assets	$ 2,003	$ 400

XML

General

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

General

General

Basis of Presentation - The unaudited consolidated financial statements for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 30, 2022, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 30, 2021.

Accounting Policies - Refer to the Company’s audited consolidated financial statements (including footnotes) for the fiscal year ended December 30, 2021, contained in the Company’s Annual Report on Form 10-K for such year, for a description of the Company’s accounting policies.

Noncontrolling Interests - The Company has an ownership interest greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is included in the accounts of the Company. The Company is the primary beneficiary of the VIE and the Company’s interest is considered a majority voting interest. The equity interest of outside owners in consolidated entities is recorded as noncontrolling interests in the consolidated balance sheets, and their share of earnings is recorded as net earnings (loss) attributable to noncontrolling interests in the consolidated statements of earnings (loss) in accordance with the partnership agreement. Due to the cumulative losses of the entity, the noncontrolling interest balance is $0 as of June 30, 2022 and December 30, 2021. The Company will not record earnings or losses from noncontrolling interest until the entity returns to profitability.

Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $16,744 and $33,967 for the 13 and 26 weeks ended June 30, 2022, respectively, and $18,475 and $36,433 for the 13 and 26 weeks ended July 1, 2021, respectively.

Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of June 30, 2022, assets held for sale consists primarily of excess land.

Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022.

Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022 or July 1, 2021.

Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the

diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.

Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Numerator:
Net earnings (loss) attributable to The Marcus Corporation	$	8,960	$	(23,366)	$	(5,942)	$	(51,496)
Denominator:
Denominator for basic EPS	31,492		31,404		31,469		31,300
Effect of dilutive employee stock options	40		—		—		—
Effect of convertible notes	9,085		—		—		—
Denominator for diluted EPS	40,617		31,404		31,469		31,300
Net earnings (loss) per share - basic:
Common Stock	$	0.29	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.26	$	(0.68)	$	(0.18)	$	(1.44)
Net earnings (loss) per share - diluted:
Common Stock	$	0.24	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.23	$	(0.68)	$	(0.18)	$	(1.44)

For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect. During the 26 weeks ended June 30, 2022, and the 13 and 26 weeks ended July 1, 2021, approximately 61,791, 165,439 and 142,746 common stock equivalents, respectively, were excluded from the computation of diluted loss per share due to the Company’s net loss. During the 26 weeks ended June 30, 2022, and the 13 and 26 weeks ended July 1, 2021, 9,084,924 shares related to the convertible notes were excluded from the computation of diluted loss per share as the effect would have been anti-dilutive.

Shareholders’ Equity - Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021 was as follows:

	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 30, 2021	$	24,345	$	7,130	$	145,656	$	289,306	$	(11,444)	$	(1,379)	$	453,614	$	—	$	453,614
Exercise of stock options	—		—		(5)		—		—		31		26		—		26
Purchase of treasury stock	—		—		—		—		—		(1,373)		(1,373)		—		(1,373)
Savings and profit-sharing contribution	56		—		900		—		—		—		956		—		956
Reissuance of treasury stock	—		—		1		—		—		8		9		—		9
Issuance of non-vested stock	78		—		(236)		—		—		158		—		—		—
Shared-based compensation	—		—		2,917		—		—		—		2,917		—		2,917
Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	19		(19)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(14,902)		531		—		(14,371)		—		(14,371)
BALANCES AT MARCH 31, 2022	$	24,498	$	7,111	$	149,234	$	274,403	$	(10,913)	$	(2,555)	$	441,778	$	—	$	441,778
Exercise of stock options	—		—		(16)		—		—		69		53		—		53
Purchase of treasury stock	—		—		—		—		—		(104)		(104)		—		(104)
Reissuance of treasury stock	—		—		(2)		—		—		9		7		—		7
Issuance of non-vested stock	—		—		(305)		—		—		305		—		—		—
Shared-based compensation	—		—		1,655		—		—		—		1,655		—		1,655
Other	—		—		(1)		1		—		—		—		—		—
Comprehensive income	—		—		—		8,960		384		—		9,344		—		9,344
BALANCES AT JUNE 30, 2022	$	24,498	$	7,111	$	150,565	$	283,364	$	(10,529)	$	(2,276)	$	452,733	$	—	$	452,733

	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 31, 2020	$	23,264	$	7,926	$	153,529	$	331,897	$	(14,933)	$	(2,960)	$	498,723	$	—	$	498,723
Adoption of ASU No. 2020-06	—		—		(16,511)		702		—		—		(15,809)		—		(15,809)
Exercise of stock options	—		—		(659)		—		—		1,951		1,292		—		1,292
Purchase of treasury stock	—		—		—		—		—		(1,181)		(1,181)		—		(1,181)
Savings and profit-sharing contribution	44		—		968		—		—		—		1,012		—		1,012
Reissuance of treasury stock	—		—		2		—		—		10		12		—		12
Issuance of non-vested stock	221		—		(367)		—		—		146		—		—		—
Shared-based compensation	—		—		1,484		—		—		—		1,484		—		1,484
Other	—		—		—		(1)		—		1		—		—		—
Conversions of Class B Common Stock	520		(520)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(28,130)		452		—		(27,678)		—		(27,678)
BALANCES AT APRIL 1, 2021	$	24,049	$	7,406	$	138,446	$	304,468	$	(14,481)	$	(2,033)	$	457,855	$	—	$	457,855
Exercise of stock options	—		—		(40)		—		—		122		82		—		82
Purchase of treasury stock	—		—		—		—		—		(73)		(73)		—		(73)
Reissuance of treasury stock	—		—		(1)		—		—		7		6		—		6
Issuance of non-vested stock	18		—		(157)		—		—		139		—		—		—
Shared-based compensation	—		—		2,668		—		—		—		2,668		—		2,668
Conversions of Class B Common Stock	275		(275)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(23,366)		356		—		(23,010)		—		(23,010)
BALANCES AT JULY 1, 2021	$	24,342	$	7,131	$	140,916	$	281,102	$	(14,125)	$	(1,838)	$	437,528	$	—	$	437,528

Accumulated Other Comprehensive Loss – Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:

	June 30, 2022		December 30, 2021
Unrecognized gain (loss) on interest rate swap agreements	$	26	$	(509)
Net unrecognized actuarial loss for pension obligation	(10,555)		$	(10,935)
	$	(10,529)	$	(11,444)

Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.

The Company’s assets and liabilities measured at fair value are classified in one of the following categories:

Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 30, 2022 and December 30, 2021, respectively, the Company’s $3,789 and $4,617 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 30, 2022 and December 30, 2021, respectively, the Company’s $44,990 and $5,000 of investments in money market accounts were valued using Level 1 pricing inputs and were included in cash and cash equivalents.

Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At June 30, 2022 and December 30, 2021, respectively, the Company’s $34 asset and $689 liability related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs.

Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At June 30, 2022 and December 30, 2021, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets and liabilities that were measured on a non-recurring basis are discussed in Note 3.

Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Service cost	$	264	$	280	$	528	$	561
Interest cost	335		301		670		601
Net amortization of prior service cost and actuarial loss	257		327		514		655
Net periodic pension cost	$	856	$	908	$	1,712	$	1,817

Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.

Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 30, 2022 is as follows:

	13 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	63,087	$	—	$	—	$	63,087
Rooms	—		28,865		—		28,865
Theatre concessions	58,147		—		—		58,147
Food and beverage	—		19,014		—		19,014
Other revenues(1)	8,203		12,872		117		21,192
Cost reimbursements	—		8,250		—		8,250
Total revenues	$	129,437	$	69,001	$	117	$	198,555
	26 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	101,504	$	—	$	—	$	101,504
Rooms	—		46,295		—		46,295
Theatre concessions	93,611		—		—		93,611
Food and beverage	—		33,525		—		33,525
Other revenues(1)	13,813		25,975		211		39,999
Cost reimbursements	—		15,863		—		15,863
Total revenues	$	208,928	$	121,658	$	211	$	330,797

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the 13 and 26 weeks ended July 1, 2021 is as follows:

	13 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	24,915	$	—	$	—	$	24,915
Rooms	—		17,332		—		17,332
Theatre concessions	23,061		—		—		23,061
Food and beverage	—		9,591		—		9,591
Other revenues(1)	4,281		9,855		95		14,231
Cost reimbursements	44		3,373		—		3,417
Total revenues	$	52,301	$	40,151	$	95	$	92,547
	26 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	35,600	$	—	$	—	$	35,600
Rooms	—		26,376		—		26,376
Theatre concessions	32,980		—		—		32,980
Food and beverage	—		15,503		—		15,503
Other revenues(1)	6,196		19,734		195		26,125
Cost reimbursements	87		6,663		—		6,750
Total revenues	$	74,863	$	68,276	$	195	$	143,334

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The Company had deferred revenue from contracts with customers of $39,355 and $39,144 as of June 30, 2022 and December 30, 2021, respectively. The Company had no contract assets as of June 30, 2022 and December 30, 2021. During the 26 weeks ended June 30, 2022, the Company recognized revenue of $9,448 that was included in deferred revenues as of December 30, 2021. During the 26 weeks ended July 1, 2021, the Company recognized revenue of $4,115 that was included in deferred revenues as of December 31, 2020. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.

As of June 30, 2022, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $3,228 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. The Company recognizes revenue as the tickets are redeemed, which is expected to occur within the next two years.

As of June 30, 2022, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $3,559 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.

The majority of the Company’s revenue is recognized in less than one year from the original contract.

New Accounting Pronouncements – During the first quarter of fiscal 2022, the Company adopted Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendments in this update provide increased transparency of government assistance including the requirement of certain disclosures in a company’s notes to the consolidated financial statements about transactions with a government. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (LIBOR), or other interbank offered rates, to alternative reference rates such as the Secured Overnight Financing Rate (SOFR). ASU No. 2020-14 is optional, effective immediately, and may be elected over time as reference rate reform activities occur, generally through December 31, 2022. The Company will evaluate the effect the new standard will have on its consolidated financial statements when a replacement rate is chosen.

XML

Impact of COVID-19 Pandemic

6 Months Ended

Jun. 30, 2022

Loss Contingency [Abstract]

Impact of COVID-19 Pandemic

Impact of COVID-19 Pandemic

The COVID-19 pandemic has had an unprecedented impact on the world and both of the Company’s business segments. As an operator of movie theatres, hotels and resorts, restaurants and bars, each of which consists of spaces where customers and guests gather in close proximity, the Company’s businesses were significantly impacted by protective actions that federal, state and local governments have taken to control the spread of the pandemic, and the customers’ reactions or responses to such actions. The extent of these protective actions and their impact on the Company’s businesses has continued to dissipate during the first half of fiscal 2022.

The Company began fiscal 2022 with all of its theatres open with normal operating days and hours. While still below pre-COVID-19 levels, attendance has continued to gradually improve as the number of vaccinated individuals increased, more films are released, and customers indicate increasing willingness to return to movie theatres.

The Company began fiscal 2022 with all eight of its company-owned and managed hotels open. The majority of the Company’s restaurants and bars in its hotels and resorts were open during the first quarters of fiscal 2022, operating under applicable state and local restrictions and guidelines, and in some cases reduced operating hours. The majority of the Company’s hotels and restaurants are generating reduced revenues as compared to pre-COVID-19 pandemic years, although hotel occupancy continues to improve as the travel activity increases.

Since the COVID-19 pandemic began, the Company has been working proactively to preserve cash and enhance liquidity. As of June 30, 2022, the Company had cash and cash equivalents of approximately $57,741 and $221,809 of availability under its $225,000 revolving credit facility. With this strong liquidity position, combined with cash generated from operations and proceeds from the sale of surplus real estate, the Company believes it is positioned to meet its obligations as they come due and continue to sustain its operations throughout fiscal 2022 and 2023, even if the properties continue to generate reduced revenues during these periods.

During the first quarter of fiscal 2022, the Company received a $22,959 federal income tax refund (including $636 of interest) related to its fiscal 2020 tax return, with the primary benefit derived from net operating loss carrybacks to prior years. The Company also received $4,335 in state theatre grants during the first quarter of fiscal 2022 that were awarded during the fourth quarter of fiscal 2021.

The Company believes that the actions that have been taken will allow it to have sufficient liquidity to meet its obligations as they come due and to comply with its debt covenants for at least 12 months from the issuance date of these unaudited consolidated financial statements. However, future compliance with the Company’s debt covenants are dependent upon the timing of new movie releases and the protective actions that federal, state and local governments have taken which impact consumer confidence and the speed of recovery of the Company’s theatres and hotels and resorts businesses. The Company’s estimates and assumptions related to future forecasted results of the Company are subject to inherent risk and uncertainty due to the ongoing impact of the COVID-19 pandemic, and actual results could differ materially from estimated amounts and impact the Company’s ability to comply with its debt covenants.

XML

Impairment Charges

6 Months Ended

Jun. 30, 2022

Asset Impairment Charges [Abstract]

Impairment Charges

3. Impairment Charges

During the 13 weeks ended July 1, 2021, the Company determined that indicators of impairment were evident at certain theatre asset groups. For certain of the theatre asset groups evaluated for impairment, the sum of the estimated undiscounted future cash flows attributable to these assets was less than their carrying amount. The Company evaluated the fair value of these assets, consisting primarily of leasehold improvements, furniture, fixtures and equipment, and operating lease right-of-use-assets less lease obligations, and determined that the fair value, measured using Level 3 pricing inputs (using estimated discounted cash flows over the life of the primary asset, including estimated sales proceeds) was less than their carrying values and recorded a $3,732 impairment loss, reducing certain property and equipment and certain operating lease right-of-use assets. The remaining net book value of the impaired assets was $10,200 as of July 1, 2021, excluding any applicable remaining lease obligations. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022.

XML

Long-Term Debt and Short-Term Borrowings

6 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Long-Term Debt and Short-Term Borrowings

Long-Term Debt and Short-Term Borrowings

Long-term debt and short-term borrowings are summarized as follows:

	June 30, 2022		December 30, 2021
Mortgage notes	$	24,203	$	24,388
Senior notes	90,000		90,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	1,158		1,356
Convertible senior notes	100,050		100,050
Payroll Protection Program loans	2,712		3,181
Revolving credit agreement	—		—
Debt issuance costs	(3,326)		(3,831)
Total debt, net of debt issuance costs	214,797		215,144
Less current maturities, net of issuance costs	11,077		10,967
Long-term debt	$	203,720	204,177
Short-term borrowings	46,628		47,346
Total debt and short-term borrowings, net of issuance costs	$	261,425	$	262,490

Credit Agreement and Short-Term Borrowings

On January 9, 2020, the Company replaced its then-existing credit agreement with several banks. On April 29, 2020, the Company entered into the First Amendment, on September 15, 2020, the Company entered into the Second Amendment, and on July 13, 2021, the Company entered into the Third Amendment (the Credit Agreement, as amended by the First Amendment, the Second Amendment and the Third Amendment, hereinafter referred to as the “Credit Agreement”).

The Credit Agreement provides for a revolving credit facility that matures on January 9, 2025 with an initial maximum aggregate amount of availability of $225,000. At June 30, 2022, there were borrowings of $0 outstanding on the revolving credit facility, which when borrowed, bear interest at LIBOR plus a margin, effectively 6.10% at June 30, 2022. Availability under the line at June 30, 2022, was $221,809, after taking into consideration outstanding letters of credit that reduce revolver availability. In conjunction with the First Amendment, the Company added an initial $90,800 term loan facility that was scheduled to mature on September 22, 2021. In conjunction with the Third Amendment, the term loan facility was reduced to $50,000 and the maturity date was extended to September 22, 2022. As of June 30, 2022, the balance of the term loan was $46,628, which is included in short-term borrowings on the consolidated balance sheet.

Borrowings under the Credit Agreement generally bear interest at a variable rate equal to: (i) LIBOR, subject to a 1% floor, plus a specified margin based upon the Company’s consolidated debt to capitalization ratio as of the most recent determination date; or (ii) the base rate (which is the highest of (a) the prime rate, (b) the greater of the federal funds rate and the overnight bank funding rate plus 0.50% or (c) the sum of 1% plus one-month LIBOR), subject to a 1% floor, plus a specified margin based upon the Company’s consolidated debt to capitalization ratio as of the most recent determination date. In addition, the Credit Agreement generally requires the Company to pay a facility fee equal to 0.125% to 0.25% of the total revolving commitment, depending on its consolidated debt to capitalization ratio, as defined in the Credit Agreement. However, pursuant to the First Amendment and the Second Amendment: (A) in respect of revolving loans, (1) the Company is charged a facility fee equal to 0.40% of the total revolving credit facility commitment and (2) the specified margin is 2.35% for LIBOR borrowings and 1.35% for ABR borrowings, which facility fee rate and specified margins will remain in effect until the end of the first fiscal quarter ending after the end of any period in which any portion of the term loan facility remains outstanding or the testing of any financial covenant in the Credit Agreement is suspended (the “specified period”); and (B) in respect of term loans, the specified margin is 2.75% for LIBOR borrowings and 1.75% for ABR borrowings, in each case, at all times.

The Credit Agreement contains various restrictions and covenants. Among other requirements, the Credit Agreement (a) limits the amount of priority debt (as defined in the Credit Agreement) held by the Company’s restricted subsidiaries to no more than 20% of the Company’s consolidated total capitalization (as defined in the Credit Agreement), (b) limits the Company’s permissible consolidated debt to capitalization ratio to a maximum of 0.55 to 1.0, (c) requires the Company to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 as of the end of the fiscal quarter ending March 30, 2023 and each fiscal quarter thereafter, (d) restricts the Company’s ability to incur additional indebtedness, pay dividends and other distributions (the restriction on dividends and other distributions does not apply to subsidiaries), and make voluntary prepayments on or defeasance of the Company’s 4.02% Senior Notes due August 2025, 4.32% Senior Notes due February 2027, the notes or certain other convertible securities, (e) requires the Company’s consolidated EBITDA not to be less than or equal to (i) $10,000 as of December 30, 2021 for the two consecutive fiscal quarters then ending, (ii) $25,000 as of March 31, 2022 for the three consecutive fiscal quarters then ending, (iii) $50,000 as of June 30, 2022 for the four consecutive fiscal quarters then ending, (iv) $65,000 as of September 29, 2022 for the four consecutive fiscal quarters then ending, or (v) $70,000 as of December 29, 2022 for the four consecutive fiscal quarters then ending, (f) requires the Company’s consolidated liquidity not to be less than or equal to (i) $100,000 as of September 30, 2021, (ii) $100,000 as of December 30, 2021, (iii) $100,000 as of March 31, 2022, (iv) $100,000 as of June 30, 2022, or (v) $50,000 as of the end of any fiscal quarter thereafter until and including the fiscal quarter ending December 29, 2022; however, each such required minimum amount of consolidated liquidity would be reduced to $50,000 for each such testing date if the initial term loans are paid in full as of such date, and (g) prohibits the Company from incurring or making capital expenditures, (i) during fiscal 2021 in excess of the sum of $40,000 plus certain adjustments, or (ii) during the Company’s 2022 fiscal year in excess of $50,000 plus certain adjustments. See Note 9 for further discussion of an amendment to the Credit Agreement covenants subsequent to the end of the second quarter of fiscal 2022.

Pursuant to the Credit Agreement, the Company is required to apply net cash proceeds received from certain events, including certain asset disposition, casualty losses, condemnations, equity issuances, capital contributions, and the incurrence of certain debt, to prepay outstanding term loans. During the 26 weeks ended June 30, 2022, approximately $820 in asset sale proceeds were applied to the term loan balance. In addition, if, at any time during the specified period, the Company’s unrestricted cash on hand exceeds $75,000, the Company is required to prepay revolving loans under the Credit Agreement by the amount of such excess, without a corresponding reduction in the revolving commitments under the Credit Agreement.

In connection with the Credit Agreement: (i) the Company has pledged, subject to certain exceptions, security interests and liens in and on (a) substantially all of its respective personal property assets and (b) certain of its respective real property assets, in each case, to secure the Credit Agreement and related obligations; and (ii) certain of the Company’s subsidiaries have guaranteed the Company’s obligations under the Credit Agreement. The foregoing security interests, liens and guaranties will remain in effect until the Collateral Release Date (as defined in the Credit Agreement).

The Credit Agreement contains customary events of default. If an event of default under the Credit Agreement occurs and is continuing, then, among other things, the lenders may declare any outstanding obligations under the Credit Agreement to be immediately due and payable and exercise rights and remedies against the pledged collateral.

Note Purchase Agreements

At June 30, 2022 and December 30, 2021, the Company’s $90,000 of senior notes consist of two Purchase Agreements maturing in 2025 through 2027, require annual principal payments in varying installments and bear interest payable semi-annually at fixed rates ranging from 4.02% to 4.32%.

Convertible Senior Notes

On September 17, 2020, the Company entered into a purchase agreement to issue and sell $100,050 aggregate principal amount of its 5.00% Convertible Senior Notes due 2025 (the “Convertible Notes.”) The Convertible Notes were issued pursuant to an indenture (the “Indenture”), dated September 22, 2020, between the Company and U.S. Bank National Association, as trustee.

The Convertible Notes bear interest from September 22, 2020 at a rate of 5.00% per year. Interest will be payable semiannually in arrears on March 15 and September 15 of each year, beginning on March 15, 2021. The Convertible Notes may bear additional interest under specified circumstances relating to the Company’s failure to comply with its reporting obligations under the Indenture or if the Convertible Notes are not freely tradeable as required by the Indenture. The Convertible Notes will mature on September 15, 2025, unless earlier repurchased or converted. Prior to March 15, 2025, the Convertible Notes will be convertible at the option of the holders only under the following circumstances: (i) during any fiscal quarter commencing after the fiscal quarter ending on December 31, 2020 (and only during such fiscal quarter), if the last reported sale price of the Common Stock for at least 20 trading days (whether or not consecutive) during a period of 30 consecutive trading days ending on, and including, the last trading day of the immediately preceding fiscal quarter is greater than or equal to 130% of the conversion price on each applicable trading day; (ii) during the five business day period immediately after any five consecutive trading day period, or the measurement period, in which the trading price per $1,000 principal amount of the Convertible Notes for each trading day of the measurement period was less than 98% of the product of the last reported sale price of the Common Stock and the conversion rate on each such trading day; or (iii) upon the occurrence of specified corporate events. On or after March 15, 2025, the Convertible Notes will be convertible at the option of the holders at any time until the close of business on the second scheduled trading day immediately preceding the maturity date.

Upon conversion, the Convertible Notes may be settled, at the Company’s election, in cash, shares of Common Stock or a combination thereof. The initial conversion rate is 90.8038 shares of Common Stock per $1,000 principal amount of the Convertible Notes (equivalent to an initial conversion price of approximately $11.01 per share of Common Stock), representing an initial conversion premium of approximately 22.5% to the $8.99 last reported sale price of the Common Stock on The New York Stock Exchange on September 17, 2020. If the Company undergoes certain fundamental changes,

holders of Convertible Notes may require the Company to repurchase for cash all or part of their Convertible Notes for a purchase price equal to 100% of the principal amount of the Convertible Notes to be repurchased, plus accrued and unpaid interest to, but excluding, the fundamental change repurchase date. In addition, if a make-whole fundamental change occurs prior to the maturity date, the Company will, under certain circumstances, increase the conversion rate for holders who convert Convertible Notes in connection with such make-whole fundamental change. The Company may not redeem the Convertible Notes before maturity and no “sinking fund” is provided for the Convertible Notes. The Indenture includes covenants customary for securities similar to the Convertible Notes, sets forth certain events of default after which the Convertible Notes may be declared immediately due and payable and sets forth certain types of bankruptcy or insolvency events of default involving the Company and certain of its subsidiaries after which the Convertible Notes become automatically due and payable.

During the Company’s fiscal 2021 second, third and fourth quarters, and the Company’s fiscal 2022 first, second and third quarters, the Company’s Convertible Notes were (are) eligible for conversion at the option of the holders as the last reported sale price of the Common Stock was greater than or equal to 130% of the applicable conversion price for at least 20 trading days during the last 30 consecutive trading days ending on the last trading day of the preceding fiscal quarter. The Company has the ability to settle the conversion in Company stock. As such, the Convertible Notes will continue to be classified as long-term. Future convertibility and resulting balance sheet classification of this liability will be monitored at each quarterly reporting date and will be analyzed dependent upon market prices of the Company’s Common Stock during the prescribed measurement period. No Convertible Notes have been converted to date and the Company does not expect any to be converted within the next 12 months.

Derivatives

The Company utilizes derivatives principally to manage market risks and reduce its exposure resulting from fluctuations in interest rates. The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objectives and strategies for undertaking various hedge transactions.

The Company entered into two interest rate swap agreements on March 1, 2018 covering $50,000 of floating rate debt. The first agreement had a notional amount of $25,000, expired March 1, 2021 and required the Company to pay interest at a defined rate of 2.559% while receiving interest at a defined variable rate of one-month LIBOR. The second agreement has a notional amount of $25,000, expires March 1, 2023 and requires the Company to pay interest at a defined rate of 2.687% while receiving interest at a defined variable rate of one-month LIBOR (1.063% at June 30, 2022). The Company’s interest rate swap agreement is considered effective and qualifies as a cash flow hedge. The Company assesses, both at the inception of each hedge and on an on-going basis, whether the derivatives that are used in its hedging transactions are highly effective in offsetting changes in cash flows of the hedged items. As of June 30, 2022, the remaining interest rate swap was considered highly effective. The fair value of the interest rate swap on June 30, 2022 was an asset of $34, which is included in other current assets in the consolidated balance sheet. The fair value of the interest rate swap on December 30, 2021, was a liability of $689, which was included in other long-term obligations in the consolidated balance sheet. The Company does not expect the interest rate swap to have a material effect on earnings over its remaining term.

XML

Leases

6 Months Ended

Jun. 30, 2022

Leases [Abstract]

Leases

Leases

The Company determines if an arrangement is a lease at inception. The Company evaluates each lease for classification as either a finance lease or an operating lease according to accounting guidance ASU No. 2016-02, Leases (Topic 842). The Company performs this evaluation at the inception of the lease and when a modification is made to a lease. The Company leases real estate and equipment with lease terms of one year to 45 years, some of which include options to extend and/or terminate the lease.

The majority of the Company’s lease agreements include fixed rental payments. For those leases with variable payments based on increases in an index subsequent to lease commencement, such payments are recognized as variable lease expense as they occur. Variable lease payments that do not depend on an index or rate, including those that depend on the Company’s performance or use of the underlying asset, are also expensed as incurred. Lease expense for operating lease payments is recognized on a straight-line basis over the lease term.

Total lease cost consists of the following:

		13 Weeks Ended				26 Weeks Ended
Lease Cost	Classification	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Finance lease costs:
Amortization of finance lease assets	Depreciation and amortization	$	696	$	668	$	1,401	$	1,380
Interest on lease liabilities	Interest expense	216		240		437		490
		$	912	$	908	$	1,838	$	1,870
Operating lease costs:
Operating lease costs	Rent expense	$	6,364	$	6,465	$	12,741	$	12,786
Variable lease cost	Rent expense	178		(158)		15		(173)
Short-term lease cost	Rent expense	36		37		72		72
		$	6,578	$	6,344	$	12,828	$	12,685

Additional information related to leases is as follows:

	13 Weeks Ended				26 Weeks Ended
Other Information	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases	$	752	$	699	$	1,336	$	1,329
Operating cash flows from finance leases	216		240		437		490
Operating cash flows from operating leases	7,012		7,899		14,136		$	15,292
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities	116		—		188		—
Operating lease liabilities	—		—		183		1,575

	June 30, 2022		December 30, 2021
Finance leases:
Property and equipment – gross	$	75,262	$	75,124
Accumulated depreciation and amortization	(59,552)		(58,197)
Property and equipment - net	$	15,710	$	16,927

Remaining lease terms and discount rates are as follows:

Lease Term and Discount Rate	June 30, 2022		December 30, 2021
Weighted-average remaining lease terms:
Finance leases	8 years		8 years
Operating leases	13 years		13 years
Weighted-average discount rates:
Finance leases	4.58	%	4.58	%
Operating leases	4.60	%	4.48	%

Deferred rent payments of approximately $1,442 for the Company’s operating leases have been included in the total operating lease obligations as of June 30, 2022, of which approximately $698 is included in long-term operating lease obligations.

XML

Income Taxes	6 Months Ended
	Jun. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income TaxesThe Company’s effective income tax rate for the 13 and 26 weeks ended June 30, 2022 was 34.7% and 23.1%, respectively, and was 26.3% and 27.0% for the 13 and 26 weeks ended and July 1, 2021, respectively. The effective tax rate for the 13 weeks ended June 30, 2022 includes discrete tax expense related to various matters. During the 26 weeks ended July 1, 2021, the Company filed income tax refund claims of $24,151 related to its fiscal 2020 tax return, of which $1,828 was received in fiscal 2021, and $22,323 was received during the 26 weeks ended June 30, 2022. An additional $636 of interest was received during the 26 weeks ended June 30, 2022 and is included within income tax benefit in the consolidated statement of earnings (loss). During the 26 weeks ended July 1, 2021, the Company received the remaining $5,900 of requested tax refunds from its fiscal 2019 tax return.

XML

Joint Venture Transactions	6 Months Ended
	Jun. 30, 2022
Investments in and Advance to Affiliates, Subsidiaries, Associates, and Joint Ventures [Abstract]
Joint Venture Transactions	Joint Venture TransactionsDuring the 26 weeks ended July 1, 2021, the Company sold its interest in an equity investment without a readily determinable fair value for $4,150 and recorded a gain of $2,079, which is included in gain (loss) on disposition of property, equipment and other assets in the consolidated statement of earnings (loss).

XML

Business Segment Information

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Business Segment Information

Business Segment InformationThe Company’s primary operations are reported in the following business segments: Theatres and Hotels/Resorts. Corporate items include amounts not allocable to the business segments. Corporate revenues consist principally of rent and the corporate operating loss includes general corporate expenses. Corporate information technology costs and accounting shared services costs are allocated to the business segments based upon several factors, including actual usage and segment revenues.

Following is a summary of business segment information for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021:

13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	129,437	$	69,001	$	117	$	198,555
Operating income (loss)	16,430		6,817		(4,354)		18,893
Depreciation and amortization	11,863		4,801		88		16,752
13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
July 1, 2021
Revenues	$	52,301	$	40,151	$	95	$	92,547
Operating loss	$	(18,215)	$	(2,239)	$	(5,656)	$	(26,110)
Depreciation and amortization	$	13,385	$	5,047	$	62	$	18,494
26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	208,928	$	121,658	$	211	$	330,797
Operating income (loss)	8,410		3,843		(10,157)		2,096
Depreciation and amortization	24,054		9,751		178		33,983
26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
July 1, 2021
Revenues	$	74,863	$	68,276	$	195	$	143,334
Operating loss	(43,854)		(7,947)		(9,970)		(61,771)
Depreciation and amortization	26,171		10,174		128		36,473

XML

Subsequent Events

6 Months Ended

Jun. 30, 2022

Subsequent Events [Abstract]

Subsequent Events

Subsequent Events

Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022 the Company repaid $46,628 of short-term borrowings, repaying in full and retiring the term loan facility maturing on September 22, 2022. In connection with the repayment of the term loan, the Company amended the Credit Agreement by entering into the Fourth Amendment which modified the consolidated fixed charge coverage covenant, reducing the requirement to maintain a consolidated fixed charge coverage ratio of at least 3.0 to 1.0 to at least 2.5 to 1 starting as of the end of the fiscal quarter ending March 30, 2023, and continuing for each fiscal quarter thereafter.

Subsequent to the end of the second quarter of fiscal 2022, on July 29, 2022, the Board of Directors declared a regular quarterly cash dividend of $0.05 per share of common stock. The dividend will be paid September 15, 2022, to shareholders of record on August 25, 2022. The Board of Directors also declared a dividend of $0.045 per share on the Class B common stock. The dividend on the Class B commons stock, which is not publicly traded, will also be paid September 15, 2022, to shareholders of record on August 25, 2022.

XML

General (Policies)

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation - The unaudited consolidated financial statements for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021 have been prepared by the Company. In the opinion of management, all adjustments, consisting of normal recurring adjustments necessary to present fairly the unaudited interim financial information at June 30, 2022, and for all periods presented, have been made. The results of operations during the interim periods are not necessarily indicative of the results of operations for the entire year or other interim periods. However, the unaudited consolidated financial statements should be read in conjunction with the Company’s audited consolidated financial statements included in the Company’s Annual Report on Form 10-K for the year ended December 30, 2021.

Noncontrolling Interests

Noncontrolling Interests - The Company has an ownership interest greater than 50% in one joint venture that is considered a Variable Interest Entity (VIE) that is included in the accounts of the Company. The Company is the primary beneficiary of the VIE and the Company’s interest is considered a majority voting interest. The equity interest of outside owners in consolidated entities is recorded as noncontrolling interests in the consolidated balance sheets, and their share of earnings is recorded as net earnings (loss) attributable to noncontrolling interests in the consolidated statements of earnings (loss) in accordance with the partnership agreement. Due to the cumulative losses of the entity, the noncontrolling interest balance is $0 as of June 30, 2022 and December 30, 2021. The Company will not record earnings or losses from noncontrolling interest until the entity returns to profitability.

Depreciation and Amortization

Depreciation and Amortization - Depreciation and amortization of property and equipment are provided using the straight-line method over the shorter of the estimated useful lives of the assets or any related lease terms. Depreciation expense totaled $16,744 and $33,967 for the 13 and 26 weeks ended June 30, 2022, respectively, and $18,475 and $36,433 for the 13 and 26 weeks ended July 1, 2021, respectively.

Assets Held for Sale

Assets Held for Sale – Long-lived assets that are expected to be sold within the next 12 months and meet the other relevant held-for-sale criteria are classified as assets held for sale and included within current assets on the consolidated balance sheet. Assets held for sale are measured at the lower of their carrying value or their fair value less costs to sell the asset. As of June 30, 2022, assets held for sale consists primarily of excess land.

Long-Lived Assets

Long-Lived Assets – The Company periodically considers whether indicators of impairment of long-lived assets held for use are present. This includes quantitative and qualitative factors, including evaluating the historical actual operating performance of the long-lived assets and assessing the potential impact of recent events and transactions impacting the long-lived assets. If such indicators are present, the Company determines if the long-lived assets are recoverable by assessing whether the sum of the estimated undiscounted future cash flows attributable to such assets is less than their carrying amounts. If the long-lived assets are not recoverable, the Company recognizes any impairment losses based on the excess of the carrying amount of the assets over their fair value. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022.

Goodwill

Goodwill – The Company reviews goodwill for impairment annually or more frequently if certain indicators arise. The Company performs its annual impairment test on the first day of the fiscal fourth quarter. There were no indicators of impairment identified during the 26 weeks ended June 30, 2022 or July 1, 2021.

Earnings (Loss) Per Share

Earnings (Loss) Per Share - Net earnings (loss) per share (EPS) of Common Stock and Class B Common Stock is computed using the two class method. Basic net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding. Diluted net earnings (loss) per share is computed by dividing net earnings (loss) by the weighted-average number of common shares outstanding, adjusted for the effect of dilutive stock options and convertible debt instruments using the if-converted method. Convertible Class B Common Stock and convertible debt instruments are reflected on an if-converted basis when dilutive to Common Stock. The computation of the

diluted net earnings (loss) per share of Common Stock assumes the conversion of Class B Common Stock in periods that have net earnings since it would be dilutive to Common Stock earnings per share, while the diluted net earnings (loss) per share of Class B Common Stock does not assume the conversion of those shares.

Holders of Common Stock are entitled to cash dividends per share equal to 110% of all dividends declared and paid on each share of Class B Common Stock. As such, the undistributed earnings (losses) for each period are allocated based on the proportionate share of entitled cash dividends.

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Numerator:
Net earnings (loss) attributable to The Marcus Corporation	$	8,960	$	(23,366)	$	(5,942)	$	(51,496)
Denominator:
Denominator for basic EPS	31,492		31,404		31,469		31,300
Effect of dilutive employee stock options	40		—		—		—
Effect of convertible notes	9,085		—		—		—
Denominator for diluted EPS	40,617		31,404		31,469		31,300
Net earnings (loss) per share - basic:
Common Stock	$	0.29	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.26	$	(0.68)	$	(0.18)	$	(1.44)
Net earnings (loss) per share - diluted:
Common Stock	$	0.24	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.23	$	(0.68)	$	(0.18)	$	(1.44)

For the periods when the Company reports a net loss, common stock equivalents are excluded from the computation of diluted loss per share as their inclusion would have an antidilutive effect. During the 26 weeks ended June 30, 2022, and the 13 and 26 weeks ended July 1, 2021, approximately 61,791, 165,439 and 142,746 common stock equivalents, respectively, were excluded from the computation of diluted loss per share due to the Company’s net loss. During the 26 weeks ended June 30, 2022, and the 13 and 26 weeks ended July 1, 2021, 9,084,924 shares related to the convertible notes were excluded from the computation of diluted loss per share as the effect would have been anti-dilutive.

Fair Value Measurements

Fair Value Measurements - Certain financial assets and liabilities are recorded at fair value in the consolidated financial statements. Some are measured on a recurring basis while others are measured on a non-recurring basis. Financial assets and liabilities measured on a recurring basis are those that are adjusted to fair value each time a financial statement is prepared. Financial assets and liabilities measured on a non-recurring basis are those that are adjusted to fair value when a significant event occurs. A fair value measurement assumes that a transaction to sell an asset or transfer a liability occurs in the principal market for the asset or liability or, in the absence of a principal market, the most advantageous market for the asset or liability.

The Company’s assets and liabilities measured at fair value are classified in one of the following categories:

Level 1 - Assets or liabilities for which fair value is based on quoted prices in active markets for identical instruments as of the reporting date. At June 30, 2022 and December 30, 2021, respectively, the Company’s $3,789 and $4,617 of debt and equity securities classified as trading were valued using Level 1 pricing inputs and were included in other current assets. At June 30, 2022 and December 30, 2021, respectively, the Company’s $44,990 and $5,000 of investments in money market accounts were valued using Level 1 pricing inputs and were included in cash and cash equivalents.

Level 2 - Assets or liabilities for which fair value is based on pricing inputs that were either directly or indirectly observable as of the reporting date. At June 30, 2022 and December 30, 2021, respectively, the Company’s $34 asset and $689 liability related to the Company’s interest rate swap contract was valued using Level 2 pricing inputs.

Level 3 - Assets or liabilities for which fair value is based on valuation models with significant unobservable pricing inputs and which result in the use of management estimates. At June 30, 2022 and December 30, 2021, none of the Company’s recorded assets or liabilities that are measured on a recurring basis at fair market value were valued using Level 3 pricing inputs. Assets and liabilities that were measured on a non-recurring basis are discussed in Note 3.

Defined Benefit Plan

Defined Benefit Plan - The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Service cost	$	264	$	280	$	528	$	561
Interest cost	335		301		670		601
Net amortization of prior service cost and actuarial loss	257		327		514		655
Net periodic pension cost	$	856	$	908	$	1,712	$	1,817

Service cost is included in Administrative expense while all other components are recorded within Other expense outside of operating income in the consolidated statements of earnings.

Revenue Recognition

Revenue Recognition – The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 30, 2022 is as follows:

	13 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	63,087	$	—	$	—	$	63,087
Rooms	—		28,865		—		28,865
Theatre concessions	58,147		—		—		58,147
Food and beverage	—		19,014		—		19,014
Other revenues(1)	8,203		12,872		117		21,192
Cost reimbursements	—		8,250		—		8,250
Total revenues	$	129,437	$	69,001	$	117	$	198,555
	26 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	101,504	$	—	$	—	$	101,504
Rooms	—		46,295		—		46,295
Theatre concessions	93,611		—		—		93,611
Food and beverage	—		33,525		—		33,525
Other revenues(1)	13,813		25,975		211		39,999
Cost reimbursements	—		15,863		—		15,863
Total revenues	$	208,928	$	121,658	$	211	$	330,797

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the 13 and 26 weeks ended July 1, 2021 is as follows:

	13 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	24,915	$	—	$	—	$	24,915
Rooms	—		17,332		—		17,332
Theatre concessions	23,061		—		—		23,061
Food and beverage	—		9,591		—		9,591
Other revenues(1)	4,281		9,855		95		14,231
Cost reimbursements	44		3,373		—		3,417
Total revenues	$	52,301	$	40,151	$	95	$	92,547
	26 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	35,600	$	—	$	—	$	35,600
Rooms	—		26,376		—		26,376
Theatre concessions	32,980		—		—		32,980
Food and beverage	—		15,503		—		15,503
Other revenues(1)	6,196		19,734		195		26,125
Cost reimbursements	87		6,663		—		6,750
Total revenues	$	74,863	$	68,276	$	195	$	143,334

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The Company had deferred revenue from contracts with customers of $39,355 and $39,144 as of June 30, 2022 and December 30, 2021, respectively. The Company had no contract assets as of June 30, 2022 and December 30, 2021. During the 26 weeks ended June 30, 2022, the Company recognized revenue of $9,448 that was included in deferred revenues as of December 30, 2021. During the 26 weeks ended July 1, 2021, the Company recognized revenue of $4,115 that was included in deferred revenues as of December 31, 2020. The majority of the Company’s deferred revenue relates to non-redeemed gift cards, advanced ticket sales and the Company’s loyalty program.

As of June 30, 2022, the amount of transaction price allocated to the remaining performance obligations under the Company’s advanced ticket sales was $3,228 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues, which is included in other accrued liabilities. The Company recognizes revenue as the tickets are redeemed, which is expected to occur within the next two years.

As of June 30, 2022, the amount of transaction price allocated to the remaining performance obligations related to the amount of Hotels and Resorts non-redeemed gift cards was $3,559 and is reflected in the Company’s consolidated balance sheet as part of deferred revenues. The Company recognizes revenue as the gift cards are redeemed, which is expected to occur within the next two years.

The majority of the Company’s revenue is recognized in less than one year from the original contract.

New Accounting Pronouncements

New Accounting Pronouncements – During the first quarter of fiscal 2022, the Company adopted Accounting Standards Update (ASU) No. 2021-10, Government Assistance (Topic 832): Disclosures by Business Entities about Government Assistance. The amendments in this update provide increased transparency of government assistance including the requirement of certain disclosures in a company’s notes to the consolidated financial statements about transactions with a government. The adoption of the new standard did not have a material effect on the Company’s consolidated financial statements.

In March 2020, the Financial Accounting Standards Board issued ASU No. 2020-04, Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting. The amendments in this update provide optional expedients and exceptions to the existing guidance on contract modifications and hedge accounting to ease the financial reporting burdens of the expected market transition from the London Interbank Offered Rate (LIBOR), or other interbank offered rates, to alternative reference rates such as the Secured Overnight Financing Rate (SOFR). ASU No. 2020-14 is optional, effective immediately, and may be elected over time as reference rate reform activities occur, generally through December 31, 2022. The Company will evaluate the effect the new standard will have on its consolidated financial statements when a replacement rate is chosen.

XML

General (Tables)

6 Months Ended

Jun. 30, 2022

Accounting Policies [Abstract]

Schedule of Earnings Per Share, Basic and Diluted

The following table illustrates the computation of Common Stock basic and diluted net earnings (loss) per share and provides a reconciliation of the number of weighted-average basic and diluted shares outstanding:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Numerator:
Net earnings (loss) attributable to The Marcus Corporation	$	8,960	$	(23,366)	$	(5,942)	$	(51,496)
Denominator:
Denominator for basic EPS	31,492		31,404		31,469		31,300
Effect of dilutive employee stock options	40		—		—		—
Effect of convertible notes	9,085		—		—		—
Denominator for diluted EPS	40,617		31,404		31,469		31,300
Net earnings (loss) per share - basic:
Common Stock	$	0.29	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.26	$	(0.68)	$	(0.18)	$	(1.44)
Net earnings (loss) per share - diluted:
Common Stock	$	0.24	$	(0.76)	$	(0.19)	$	(1.71)
Class B Common Stock	$	0.23	$	(0.68)	$	(0.18)	$	(1.44)

Schedule of Stockholders Equity

Activity impacting total shareholders’ equity attributable to The Marcus Corporation and noncontrolling interest for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021 was as follows:

	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 30, 2021	$	24,345	$	7,130	$	145,656	$	289,306	$	(11,444)	$	(1,379)	$	453,614	$	—	$	453,614
Exercise of stock options	—		—		(5)		—		—		31		26		—		26
Purchase of treasury stock	—		—		—		—		—		(1,373)		(1,373)		—		(1,373)
Savings and profit-sharing contribution	56		—		900		—		—		—		956		—		956
Reissuance of treasury stock	—		—		1		—		—		8		9		—		9
Issuance of non-vested stock	78		—		(236)		—		—		158		—		—		—
Shared-based compensation	—		—		2,917		—		—		—		2,917		—		2,917
Other	—		—		1		(1)		—		—		—		—		—
Conversions of Class B Common Stock	19		(19)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(14,902)		531		—		(14,371)		—		(14,371)
BALANCES AT MARCH 31, 2022	$	24,498	$	7,111	$	149,234	$	274,403	$	(10,913)	$	(2,555)	$	441,778	$	—	$	441,778
Exercise of stock options	—		—		(16)		—		—		69		53		—		53
Purchase of treasury stock	—		—		—		—		—		(104)		(104)		—		(104)
Reissuance of treasury stock	—		—		(2)		—		—		9		7		—		7
Issuance of non-vested stock	—		—		(305)		—		—		305		—		—		—
Shared-based compensation	—		—		1,655		—		—		—		1,655		—		1,655
Other	—		—		(1)		1		—		—		—		—		—
Comprehensive income	—		—		—		8,960		384		—		9,344		—		9,344
BALANCES AT JUNE 30, 2022	$	24,498	$	7,111	$	150,565	$	283,364	$	(10,529)	$	(2,276)	$	452,733	$	—	$	452,733

	Common Stock		Class B Common Stock		Capital in Excess of Par		Retained Earnings		Accumulated Other Comprehensive Income (Loss)		Treasury Stock		Shareholders’ Equity Attributable to The Marcus Corporation		Non- controlling Interest		Total Equity
BALANCES AT DECEMBER 31, 2020	$	23,264	$	7,926	$	153,529	$	331,897	$	(14,933)	$	(2,960)	$	498,723	$	—	$	498,723
Adoption of ASU No. 2020-06	—		—		(16,511)		702		—		—		(15,809)		—		(15,809)
Exercise of stock options	—		—		(659)		—		—		1,951		1,292		—		1,292
Purchase of treasury stock	—		—		—		—		—		(1,181)		(1,181)		—		(1,181)
Savings and profit-sharing contribution	44		—		968		—		—		—		1,012		—		1,012
Reissuance of treasury stock	—		—		2		—		—		10		12		—		12
Issuance of non-vested stock	221		—		(367)		—		—		146		—		—		—
Shared-based compensation	—		—		1,484		—		—		—		1,484		—		1,484
Other	—		—		—		(1)		—		1		—		—		—
Conversions of Class B Common Stock	520		(520)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(28,130)		452		—		(27,678)		—		(27,678)
BALANCES AT APRIL 1, 2021	$	24,049	$	7,406	$	138,446	$	304,468	$	(14,481)	$	(2,033)	$	457,855	$	—	$	457,855
Exercise of stock options	—		—		(40)		—		—		122		82		—		82
Purchase of treasury stock	—		—		—		—		—		(73)		(73)		—		(73)
Reissuance of treasury stock	—		—		(1)		—		—		7		6		—		6
Issuance of non-vested stock	18		—		(157)		—		—		139		—		—		—
Shared-based compensation	—		—		2,668		—		—		—		2,668		—		2,668
Conversions of Class B Common Stock	275		(275)		—		—		—		—		—		—		—
Comprehensive income (loss)	—		—		—		(23,366)		356		—		(23,010)		—		(23,010)
BALANCES AT JULY 1, 2021	$	24,342	$	7,131	$	140,916	$	281,102	$	(14,125)	$	(1,838)	$	437,528	$	—	$	437,528

Schedule of Accumulated Other Comprehensive Income (Loss)

Accumulated other comprehensive loss presented in the accompanying consolidated balance sheets consists of the following, all presented net of tax:

	June 30, 2022		December 30, 2021
Unrecognized gain (loss) on interest rate swap agreements	$	26	$	(509)
Net unrecognized actuarial loss for pension obligation	(10,555)		$	(10,935)
	$	(10,529)	$	(11,444)

Schedule of Defined Benefit Plan

The components of the net periodic pension cost of the Company’s unfunded nonqualified, defined-benefit plan are as follows:

	13 Weeks Ended				26 Weeks Ended
	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Service cost	$	264	$	280	$	528	$	561
Interest cost	335		301		670		601
Net amortization of prior service cost and actuarial loss	257		327		514		655
Net periodic pension cost	$	856	$	908	$	1,712	$	1,817

Schedule of Disaggregation of Revenue

The disaggregation of revenues by business segment for the 13 and 26 weeks ended June 30, 2022 is as follows:

	13 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	63,087	$	—	$	—	$	63,087
Rooms	—		28,865		—		28,865
Theatre concessions	58,147		—		—		58,147
Food and beverage	—		19,014		—		19,014
Other revenues(1)	8,203		12,872		117		21,192
Cost reimbursements	—		8,250		—		8,250
Total revenues	$	129,437	$	69,001	$	117	$	198,555
	26 Weeks Ended June 30, 2022
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	101,504	$	—	$	—	$	101,504
Rooms	—		46,295		—		46,295
Theatre concessions	93,611		—		—		93,611
Food and beverage	—		33,525		—		33,525
Other revenues(1)	13,813		25,975		211		39,999
Cost reimbursements	—		15,863		—		15,863
Total revenues	$	208,928	$	121,658	$	211	$	330,797

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

The disaggregation of revenues by business segment for the 13 and 26 weeks ended July 1, 2021 is as follows:

	13 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	24,915	$	—	$	—	$	24,915
Rooms	—		17,332		—		17,332
Theatre concessions	23,061		—		—		23,061
Food and beverage	—		9,591		—		9,591
Other revenues(1)	4,281		9,855		95		14,231
Cost reimbursements	44		3,373		—		3,417
Total revenues	$	52,301	$	40,151	$	95	$	92,547
	26 Weeks Ended July 1, 2021
	Theatres		Hotels/Resorts		Corporate		Total
Theatre admissions	$	35,600	$	—	$	—	$	35,600
Rooms	—		26,376		—		26,376
Theatre concessions	32,980		—		—		32,980
Food and beverage	—		15,503		—		15,503
Other revenues(1)	6,196		19,734		195		26,125
Cost reimbursements	87		6,663		—		6,750
Total revenues	$	74,863	$	68,276	$	195	$	143,334

(1)Included in other revenues is an immaterial amount related to rental income that is not considered revenue from contracts with customers.

XML

Long-Term Debt and Short-Term Borrowings (Tables)

6 Months Ended

Jun. 30, 2022

Debt Disclosure [Abstract]

Schedule of Long-term debt and short-term borrowings

Long-term debt and short-term borrowings are summarized as follows:

	June 30, 2022		December 30, 2021
Mortgage notes	$	24,203	$	24,388
Senior notes	90,000		90,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	1,158		1,356
Convertible senior notes	100,050		100,050
Payroll Protection Program loans	2,712		3,181
Revolving credit agreement	—		—
Debt issuance costs	(3,326)		(3,831)
Total debt, net of debt issuance costs	214,797		215,144
Less current maturities, net of issuance costs	11,077		10,967
Long-term debt	$	203,720	204,177
Short-term borrowings	46,628		47,346
Total debt and short-term borrowings, net of issuance costs	$	261,425	$	262,490

XML

Leases (Tables)

6 Months Ended

Jun. 30, 2022

Leases [Abstract]

Schedule of Lease, Cost

Total lease cost consists of the following:

		13 Weeks Ended				26 Weeks Ended
Lease Cost	Classification	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Finance lease costs:
Amortization of finance lease assets	Depreciation and amortization	$	696	$	668	$	1,401	$	1,380
Interest on lease liabilities	Interest expense	216		240		437		490
		$	912	$	908	$	1,838	$	1,870
Operating lease costs:
Operating lease costs	Rent expense	$	6,364	$	6,465	$	12,741	$	12,786
Variable lease cost	Rent expense	178		(158)		15		(173)
Short-term lease cost	Rent expense	36		37		72		72
		$	6,578	$	6,344	$	12,828	$	12,685

Schedule of Other Information Related to Leases

Additional information related to leases is as follows:

	13 Weeks Ended				26 Weeks Ended
Other Information	June 30, 2022		July 1, 2021		June 30, 2022		July 1, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases	$	752	$	699	$	1,336	$	1,329
Operating cash flows from finance leases	216		240		437		490
Operating cash flows from operating leases	7,012		7,899		14,136		$	15,292
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities	116		—		188		—
Operating lease liabilities	—		—		183		1,575

	June 30, 2022		December 30, 2021
Finance leases:
Property and equipment – gross	$	75,262	$	75,124
Accumulated depreciation and amortization	(59,552)		(58,197)
Property and equipment - net	$	15,710	$	16,927

Schedule of Lease Term and Discount Rate

Remaining lease terms and discount rates are as follows:

Lease Term and Discount Rate	June 30, 2022		December 30, 2021
Weighted-average remaining lease terms:
Finance leases	8 years		8 years
Operating leases	13 years		13 years
Weighted-average discount rates:
Finance leases	4.58	%	4.58	%
Operating leases	4.60	%	4.48	%

XML

Business Segment Information (Tables)

6 Months Ended

Jun. 30, 2022

Segment Reporting [Abstract]

Schedule of Segment Reporting Information, by Segment

Following is a summary of business segment information for the 13 and 26 weeks ended June 30, 2022 and July 1, 2021:

13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	129,437	$	69,001	$	117	$	198,555
Operating income (loss)	16,430		6,817		(4,354)		18,893
Depreciation and amortization	11,863		4,801		88		16,752
13 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
July 1, 2021
Revenues	$	52,301	$	40,151	$	95	$	92,547
Operating loss	$	(18,215)	$	(2,239)	$	(5,656)	$	(26,110)
Depreciation and amortization	$	13,385	$	5,047	$	62	$	18,494
26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
June 30, 2022
Revenues	$	208,928	$	121,658	$	211	$	330,797
Operating income (loss)	8,410		3,843		(10,157)		2,096
Depreciation and amortization	24,054		9,751		178		33,983
26 Weeks Ended	Theatres		Hotels/ Resorts		Corporate Items		Total
July 1, 2021
Revenues	$	74,863	$	68,276	$	195	$	143,334
Operating loss	(43,854)		(7,947)		(9,970)		(61,771)
Depreciation and amortization	26,171		10,174		128		36,473

XML

General - Additional information (Details) - USD ($)	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021	Dec. 30, 2021
Summary of Significant Accounting Policies [Line Items]
Noncontrolling interest	$ 0		$ 0		$ 0
Depreciation	16,744,000	$ 18,475,000	$ 33,967,000	$ 36,433,000
Percentage of cash dividends			110.00%
Deferred revenue	39,355,000		$ 39,355,000		39,144,000
Contract assets	0		0		0
Deferred revenue, revenue recognized			9,448,000	$ 4,115,000
Remaining performance obligation related to advanced ticket sales	3,228,000		3,228,000
Remaining performance obligation related to hotels gift cards			3,559,000
Level 1
Summary of Significant Accounting Policies [Line Items]
Trading securities, fair value	3,789,000		3,789,000		4,617,000
Level 1 | Money Market Funds
Summary of Significant Accounting Policies [Line Items]
Trading securities, fair value	44,990,000		44,990,000		5,000,000
Level 2
Summary of Significant Accounting Policies [Line Items]
Fair value of the interest rate swaps, assets	34,000		34,000
Fair value of the interest rate swaps, liabilities					689,000
Level 3 | Recurring
Summary of Significant Accounting Policies [Line Items]
Fair value, asset (liability)	$ 0		$ 0		$ 0
Common Stock
Summary of Significant Accounting Policies [Line Items]
Shares related to the convertible notes were excluded from the computation of diluted earnings per share (in shares)		165,439	61,791	142,746
Shares Related to Convertible Notes
Summary of Significant Accounting Policies [Line Items]
Shares related to the convertible notes were excluded from the computation of diluted earnings per share (in shares)		9,084,924	9,084,924	9,084,924

XML

General - Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Numerator:
Net earnings (loss) attributable to The Marcus Corporation	$ 8,960	$ (23,366)	$ (5,942)	$ (51,496)
Denominator:
Denominator for basic EPS (in shares)	31,492	31,404	31,469	31,300
Effect of dilutive employee stock options (in shares)	40	0	0	0
Effect of convertible notes (in shares)	9,085	0	0	0
Denominator for diluted EPS (in shares)	40,617	31,404	31,469	31,300
Common Stock
Net earnings (loss) per share - basic:
Common stock (in dollars per share)	$ 0.29	$ (0.76)	$ (0.19)	$ (1.71)
Net earnings (loss) per share - diluted:
Common stock (in dollars per share)	0.24	(0.76)	(0.19)	(1.71)
Class B Common Stock
Net earnings (loss) per share - basic:
Common stock (in dollars per share)	0.26	(0.68)	(0.18)	(1.44)
Net earnings (loss) per share - diluted:
Common stock (in dollars per share)	$ 0.23	$ (0.68)	$ (0.18)	$ (1.44)

XML

General - Shareholders' Equity (Details) - USD ($) $ in Thousands	3 Months Ended				6 Months Ended
	Jun. 30, 2022	Mar. 31, 2022	Jul. 01, 2021	Apr. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Accounting standards update [Extensible Enumeration]				Accounting Standards Update 2020-06 [Member]
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	$ 441,778	$ 453,614	$ 457,855	$ 498,723	$ 453,614	$ 498,723
Exercise of stock options	53	26	82	1,292
Purchase of treasury stock	(104)	(1,373)	(73)	(1,181)
Savings and profit-sharing contribution		956		1,012
Reissuance of treasury stock	7	9	6	12
Issuance of non-vested stock	0	0	0	0
Shared-based compensation	1,655	2,917	2,668	1,484
Other	0	0		0
Conversions of Class B Common Stock		0	0	0
Comprehensive income (loss)	9,344	(14,371)	(23,010)	(27,678)	(5,027)	(50,688)
Ending balance	452,733	441,778	437,528	457,855	452,733	437,528
Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				(15,809)		(15,809)
Shareholders’ Equity Attributable to The Marcus Corporation
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	441,778	453,614	457,855	498,723	453,614	498,723
Exercise of stock options	53	26	82	1,292
Purchase of treasury stock	(104)	(1,373)	(73)	(1,181)
Savings and profit-sharing contribution		956		1,012
Reissuance of treasury stock	7	9	6	12
Issuance of non-vested stock	0	0
Shared-based compensation	1,655	2,917	2,668	1,484
Other	0	0		0
Conversions of Class B Common Stock		0
Comprehensive income (loss)	9,344	(14,371)	(23,010)	(27,678)
Ending balance	452,733	441,778	437,528	457,855	452,733	437,528
Shareholders’ Equity Attributable to The Marcus Corporation | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				(15,809)		(15,809)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	24,498	24,345	24,049	23,264	24,345	23,264
Savings and profit-sharing contribution		56		44
Issuance of non-vested stock	0	78	18	221
Conversions of Class B Common Stock		19	275	520
Ending balance	24,498	24,498	24,342	24,049	24,498	24,342
Capital in Excess of Par
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	149,234	145,656	138,446	153,529	145,656	153,529
Exercise of stock options	(16)	(5)	(40)	(659)
Savings and profit-sharing contribution		900		968
Reissuance of treasury stock	(2)	1	(1)	2
Issuance of non-vested stock	(305)	(236)	(157)	(367)
Shared-based compensation	1,655	2,917	2,668	1,484
Other	(1)	1
Ending balance	150,565	149,234	140,916	138,446	150,565	140,916
Capital in Excess of Par | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				(16,511)		(16,511)
Retained Earnings
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	274,403	289,306	304,468	331,897	289,306	331,897
Other	1	(1)		(1)
Comprehensive income (loss)	8,960	(14,902)	(23,366)	(28,130)
Ending balance	283,364	274,403	281,102	304,468	283,364	281,102
Retained Earnings | Cumulative Effect, Period of Adoption, Adjustment
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance				702		702
Accumulated Other Comprehensive Income (Loss)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(10,913)	(11,444)	(14,481)	(14,933)	(11,444)	(14,933)
Comprehensive income (loss)	384	531	356	452
Ending balance	(10,529)	(10,913)	(14,125)	(14,481)	(10,529)	(14,125)
Treasury Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	(2,555)	(1,379)	(2,033)	(2,960)	(1,379)	(2,960)
Exercise of stock options	69	31	122	1,951
Purchase of treasury stock	(104)	(1,373)	(73)	(1,181)
Reissuance of treasury stock	9	8	7	10
Issuance of non-vested stock	305	158	139	146
Other				1
Ending balance	(2,276)	(2,555)	(1,838)	(2,033)	(2,276)	(1,838)
Non- controlling Interest
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	0	0	0	0	0	0
Comprehensive income (loss)			0	0
Ending balance	0	0	0	0	0	0
Class B Common Stock | Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning balance	7,111	7,130	7,406	7,926	7,130	7,926
Conversions of Class B Common Stock		(19)	(275)	(520)
Ending balance	$ 7,111	$ 7,111	$ 7,131	$ 7,406	$ 7,111	$ 7,131

XML

General - Accumulated Other Comprehensive Loss (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 30, 2021
Accounting Policies [Abstract]
Unrecognized gain (loss) on interest rate swap agreements	$ 26	$ (509)
Net unrecognized actuarial loss for pension obligation	(10,555)	(10,935)
Accumulated other comprehensive loss	$ (10,529)	$ (11,444)

XML

General - Defined Benefit Plan (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Accounting Policies [Abstract]
Service cost	$ 264	$ 280	$ 528	$ 561
Interest cost	335	301	670	601
Net amortization of prior service cost and actuarial loss	257	327	514	655
Net periodic pension cost	$ 856	$ 908	$ 1,712	$ 1,817

XML

General - Revenue Recognition (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Summary of Significant Accounting Policies [Line Items]
Revenues	$ 190,305	$ 89,130	$ 314,934	$ 136,584
Cost reimbursements	8,250	3,417	15,863	6,750
Total revenues	198,555	92,547	330,797	143,334
Theatre admissions
Summary of Significant Accounting Policies [Line Items]
Revenues	63,087	24,915	101,504	35,600
Rooms
Summary of Significant Accounting Policies [Line Items]
Revenues	28,865	17,332	46,295	26,376
Theatre concessions
Summary of Significant Accounting Policies [Line Items]
Revenues	58,147	23,061	93,611	32,980
Food and beverage
Summary of Significant Accounting Policies [Line Items]
Revenues	19,014	9,591	33,525	15,503
Other revenues
Summary of Significant Accounting Policies [Line Items]
Revenues	21,192	14,231	39,999	26,125
Theatres
Summary of Significant Accounting Policies [Line Items]
Cost reimbursements	0	44	0	87
Total revenues	129,437	52,301	208,928	74,863
Theatres | Theatre admissions
Summary of Significant Accounting Policies [Line Items]
Revenues	63,087	24,915	101,504	35,600
Theatres | Theatre concessions
Summary of Significant Accounting Policies [Line Items]
Revenues	58,147	23,061	93,611	32,980
Theatres | Other revenues
Summary of Significant Accounting Policies [Line Items]
Revenues	8,203	4,281	13,813	6,196
Hotels/Resorts
Summary of Significant Accounting Policies [Line Items]
Cost reimbursements	8,250	3,373	15,863	6,663
Total revenues	69,001	40,151	121,658	68,276
Hotels/Resorts | Rooms
Summary of Significant Accounting Policies [Line Items]
Revenues	28,865	17,332	46,295	26,376
Hotels/Resorts | Food and beverage
Summary of Significant Accounting Policies [Line Items]
Revenues	19,014	9,591	33,525	15,503
Hotels/Resorts | Other revenues
Summary of Significant Accounting Policies [Line Items]
Revenues	12,872	9,855	25,975	19,734
Corporate
Summary of Significant Accounting Policies [Line Items]
Total revenues	117	95	211	195
Corporate | Other revenues
Summary of Significant Accounting Policies [Line Items]
Revenues	$ 117	$ 95	$ 211	$ 195

XML

Impact of COVID-19 Pandemic (Details)	3 Months Ended	6 Months Ended
	Mar. 31, 2022 USD ($)	Jun. 30, 2022 USD ($)	Jul. 01, 2021 USD ($)	Dec. 30, 2021 USD ($) hotel
Debt Instrument [Line Items]
Number of hotels opened | hotel				8
Cash and cash equivalents		$ 57,741,000		$ 17,658,000
Proceeds from tax refunds		22,323,000	$ 5,900,000
Grants received	$ 4,335,000
Federal
Debt Instrument [Line Items]
Proceeds from tax refunds	$ 22,959,000
Interest from income tax refunds		636,000
Revolving Credit Facility
Debt Instrument [Line Items]
Available facility		221,809,000
Maximum borrowing capacity		$ 225,000,000

XML

Impairment Charges (Detail) - Level 3 $ in Thousands	Jul. 01, 2021 USD ($)
Impairment Charge [Line Items]
Impairment of fixed assets	$ 3,732
Impaired assets, fair value	$ 10,200

XML

Long-Term Debt and Short-Term Borrowings - Summary for Debt (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 30, 2022	Dec. 30, 2021
Debt Disclosure [Abstract]
Principal and interest payments	$ 39
Interest rate of unsecured term note	5.75%
Mortgage notes	$ 24,203	$ 24,388
Senior notes	90,000	90,000
Unsecured term note due February 2025, with monthly principal and interest payments of $39, bearing interest at 5.75%	1,158	1,356
Convertible senior notes	100,050	100,050
Payroll Protection Program loans	2,712	3,181
Revolving credit agreement	0	0
Debt issuance costs	(3,326)	(3,831)
Total debt, net of debt issuance costs	214,797	215,144
Less current maturities, net of issuance costs	11,077	10,967
Long-term debt	203,720	204,177
Short-term borrowings	46,628	47,346
Total debt and short-term borrowings, net of issuance costs	$ 261,425	$ 262,490

XML

Long-Term Debt and Short-Term Borrowings - Additional Information (Details)								3 Months Ended	6 Months Ended	12 Months Ended	15 Months Ended
	Dec. 31, 2022 USD ($)	Dec. 29, 2022 USD ($)	Sep. 29, 2022 USD ($)	Jun. 30, 2022 USD ($)	Mar. 31, 2022 USD ($)	Dec. 30, 2021 USD ($)	Sep. 17, 2020 USD ($) $ / shares	Mar. 30, 2023	Jun. 30, 2022 USD ($) agreement	Dec. 30, 2021 USD ($) agreement	Jun. 30, 2022 USD ($)	Sep. 30, 2021 USD ($)	Jul. 13, 2021 USD ($)	Sep. 22, 2020	Apr. 29, 2020 USD ($)	Mar. 01, 2018 USD ($) instrument
Covenant for EBITDA					$ 25,000,000	$ 10,000,000			$ 50,000,000
Covenant for the amount of liquidity				$ 100,000,000	$ 100,000,000	100,000,000			100,000,000	$ 100,000,000	$ 100,000,000	$ 100,000,000
Minimum amount of reduction in liquidity for covenant				50,000,000					50,000,000		50,000,000
Covenant regarding the capital expenditure										40,000,000
Proceeds from sale of assets									820,000
Unrestricted cash on had requirements				75,000,000					75,000,000		75,000,000
Senior notes				90,000,000		90,000,000			$ 90,000,000	90,000,000	$ 90,000,000
Trading period									20 days		20 days
Threshold trading days									30 days		30 days
Threshold percentage of conversion price on each applicable trading day											130.00%
Amount of hedged item																$ 50,000,000
Interest Rate Swap
Derivative, Number of Instruments Held | instrument																2
Notional amount																$ 25,000,000
Fair value of the interest rate swaps, assets				34,000					$ 34,000		$ 34,000
Fair value of the interest rate swaps, liabilities						$ 689,000				$ 689,000
Interest Rate Swap Agreements One
Fixed interest rate						2.559%				2.559%						2.559%
Interest Rate Swap Agreements Two
Notional amount				$ 25,000,000					$ 25,000,000		$ 25,000,000
Fixed interest rate				2.687%					2.687%		2.687%
Forecast
Covenant for EBITDA		$ 70,000,000	$ 65,000,000
Covenant for the amount of liquidity		$ 50,000,000
Covenant regarding the capital expenditure	$ 50,000,000
LIBOR | Interest Rate Swap
Variable interest rate				1.063%					1.063%		1.063%
Term Loan A
Term loan current				$ 46,628,000					$ 46,628,000		$ 46,628,000
Term Loan A | LIBOR
Specified margin (as a percent)									2.75%
Term Loan A | ABR
Specified margin (as a percent)									1.75%
Term Loan A | Term Loan, First Amendment
Face amount															$ 90,800,000
Term Loan A | Term Loan, Third Amendment
Face amount													$ 50,000,000
Note Purchase Agreement
Number of purchase agreements | agreement									2	2
Note Purchase Agreement | Minimum
Interest rate (as a percent)				4.02%		4.02%			4.02%	4.02%	4.02%
Note Purchase Agreement | Maximum
Interest rate (as a percent)				4.32%		4.32%			4.32%	4.32%	4.32%
Convertible Debt
Face amount							$ 100,050,000
Interest rate (as a percent)							5.00%							5.00%
Threshold percentage of conversion price on each applicable trading day									98.00%
Conversion rate							90.8038
Initial conversion price (in dollars per share) | $ / shares							$ 11.01
Initial conversion premium							22.50%
Share price (in dollars per share) | $ / shares							$ 8.99
Purchase price as a percentage of principal amount							100.00%
Revolving Credit Facility
Maximum borrowing capacity				$ 225,000,000					$ 225,000,000		$ 225,000,000
Borrowing outstanding				0					0		0
Available facility				$ 221,809,000					$ 221,809,000		$ 221,809,000
Facility fee (as a percent)									0.40%
Revolving Credit Facility | LIBOR
Specified margin (as a percent)				6.10%
Revolving Credit Facility | ABR
Specified margin (as a percent)									1.35%
Credit Agreement
Interest rate (as a percent)				1.00%					1.00%		1.00%
Priority debt as a percentage of consolidated total capitalization									20.00%
Consolidated debt to capitalization ratio									0.55
Credit Agreement | Forecast
Consolidated fixed charge coverage ratio								3.0
Credit Agreement | Secured Overnight Financing Rate (SOFR)
Specified margin (as a percent)									0.50%
Credit Agreement | Minimum
Facility fee (as a percent)									0.125%
Credit Agreement | Maximum
Facility fee (as a percent)									0.25%
Credit Agreement | Subject to 1% Floor | LIBOR
Specified margin (as a percent)									1.00%
ABR | LIBOR
Specified margin (as a percent)									2.35%

XML

Leases - Additional Information (Details) $ in Thousands	Jun. 30, 2022 USD ($)
Deferred rent payments under operating lease	$ 1,442
Long-term operating lease obligations
Deferred rent payments under operating lease	$ 698
Minimum
Lease terms (in years)	1 year
Maximum
Lease terms (in years)	45 years

XML

Leases - Total lease cost (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Finance lease costs:
Amortization of finance lease assets	$ 696	$ 668	$ 1,401	$ 1,380
Interest on lease liabilities	216	240	437	490
Total finance lease costs	912	908	1,838	1,870
Operating lease costs:
Operating lease costs	6,364	6,465	12,741	12,786
Variable lease cost	178	(158)	15	(173)
Short-term lease cost	36	37	72	72
Total operating lease costs	$ 6,578	$ 6,344	$ 12,828	$ 12,685

XML

Leases - Other Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Cash paid for amounts included in the measurement of lease liabilities:
Financing cash flows from finance leases	$ 752	$ 699	$ 1,336	$ 1,329
Operating cash flows from finance leases	216	240	437	490
Operating cash flows from operating leases	7,012	7,899	14,136	15,292
Right of use assets obtained in exchange for new lease obligations:
Finance lease liabilities	116	0	188	0
Operating lease liabilities	$ 0	$ 0	$ 183	$ 1,575

XML

Leases - Finance leases (Details) - USD ($) $ in Thousands	Jun. 30, 2022	Dec. 30, 2021
Finance leases:
Property and equipment – gross	$ 1,526,086	$ 1,509,450
Accumulated depreciation and amortization	(770,460)	(738,258)
Property and equipment - net	755,626	771,192
Finance leases
Finance leases:
Property and equipment – gross	75,262	75,124
Accumulated depreciation and amortization	(59,552)	(58,197)
Property and equipment - net	$ 15,710	$ 16,927

XML

Leases - Lease Term and Discount Rate (Details)	Jun. 30, 2022	Dec. 30, 2021
Weighted-average remaining lease terms:
Finance leases	8 years	8 years
Operating leases	13 years	13 years
Weighted-average discount rates:
Finance leases	4.58%	4.58%
Operating leases	4.60%	4.48%

XML

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021	Dec. 30, 2021
Income Tax Disclosure [Abstract]
Effective income tax rate, percent	34.70%	26.30%	23.10%	27.00%
Income tax refund claims				$ 24,151
Proceeds from income tax refunds					$ 1,828
Proceeds from tax refunds			$ 22,323	$ 5,900
Additional interest received			$ 636

XML

Joint Venture Transactions (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Gain on disposition of property, equipment and other assets	$ (69)	$ (164)	$ 355	$ 2,040
Corporate Joint Venture
Sale of interest in equity investment				4,150
Gain on disposition of property, equipment and other assets				$ 2,079

XML

Business Segment Information (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 30, 2022	Jul. 01, 2021	Jun. 30, 2022	Jul. 01, 2021
Segment Reporting Information [Line Items]
Revenues	$ 198,555	$ 92,547	$ 330,797	$ 143,334
Operating income (loss)	18,893	(26,110)	2,096	(61,771)
Depreciation and amortization	16,752	18,494	33,983	36,473
Theatres
Segment Reporting Information [Line Items]
Revenues	129,437	52,301	208,928	74,863
Operating income (loss)	16,430	(18,215)	8,410	(43,854)
Depreciation and amortization	11,863	13,385	24,054	26,171
Hotels/ Resorts
Segment Reporting Information [Line Items]
Revenues	69,001	40,151	121,658	68,276
Operating income (loss)	6,817	(2,239)	3,843	(7,947)
Depreciation and amortization	4,801	5,047	9,751	10,174
Corporate Items
Segment Reporting Information [Line Items]
Revenues	117	95	211	195
Operating income (loss)	(4,354)	(5,656)	(10,157)	(9,970)
Depreciation and amortization	$ 88	$ 62	$ 178	$ 128

XML

Subsequent Events (Details) $ / shares in Units, $ in Thousands		6 Months Ended
	Jul. 29, 2022 USD ($) $ / shares	Jun. 30, 2022 USD ($)	Jul. 01, 2021 USD ($)
Subsequent Event [Line Items]
Repayments on short-term borrowings | $		$ 820	$ 4,150
Credit Agreement | Maximum
Subsequent Event [Line Items]
Fixed charge coverage ratio requirements		3.0
Subsequent Event
Subsequent Event [Line Items]
Repayments on short-term borrowings | $	$ 46,628
Common Stock, Dividends, Per Share, Declared | $ / shares	$ 0.05
Subsequent Event | Class B Common Stock
Subsequent Event [Line Items]
Common Stock, Dividends, Per Share, Declared | $ / shares	$ 0.045
Subsequent Event | Credit Agreement | Minimum
Subsequent Event [Line Items]
Fixed charge coverage ratio requirements	2.5